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Professor Jeffrey H. Omens, Chair 
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Cardiovascular disease is the primary cause of death in the United States and presents 
a significant challenge for researchers and clinicians due to the complexity and non-
uniformity of structure-function relationships in the heart. The largest of the four heart 
chambers, the left ventricle, must pump efficiently and adapt to changes in demand or blood 
 xix 
flow, which the normal heart does remarkably well. However, in disease states, the 
compensatory response of the myocardium and persistent overloading can cause remodeling 
to become counter-productive. 
Two of the major diseases contributing to overall cardiac morbidity and mortality are 
hypertension and myocardial infarction. While much is understood about the forms of 
remodeling and the associated dysfunction that occur in these disease states, they are usually 
measured at the scale of the entire organ (e.g. ejection fraction), or only in a select region of 
tissue. Many studies have shown regional variations in structural properties in the normal 
heart, but a comprehensive understanding of regional remodeling and the resultant functional 
consequences in disease states is lacking. Thus, the primary aims of this dissertation are to: 
1. Determine the effect of pressure overload on regional distributions of 
electrophysiological and calcium handling proteins in the rat left ventricle. 
2. Test the hypothesis that regional gradients in structural properties such as myocyte 
geometry are diminished in pressure overload. 
a. Determine whether regional variations in these structural features could be 
comprehensively and non-invasively quantified using DT-MRI. 
3. Compare the measured size of a scar after myocardial infarction using traditional 
methods to the size of the corresponding region of dysfunction using a novel 3D 
MRI-based approach. 
A better understanding of regional variations in normal and diseased ventricles will be 
valuable in identifying potential targets for therapeutic intervention to slow, prevent, or 
reverse adverse remodeling in patients with cardiac diseases such as hypertension or 
 xx 
infarction, and provide insight as to the mechanisms by which regional variations contribute 
to overall pump function. 
 
 1 
1. Transmural Gradients of Myocardial Structure and Mechanics: Implications for 
Fiber Stress and Strain in Pressure Overload 
The heart is a vital organ, supplying life-sustaining oxygen- and nutrient-rich blood to 
the entire organism, as well as removing cell waste and carbon dioxide. This is achieved by a 
cyclical pumping motion of the atria and ventricles, which beat approximately 100,000 times 
per day, 40 million times per year, or roughly 3 billion times in the lifetime of an average 
human. To achieve such longevity and performance, the structural composition of the heart at 
each spatial scale, from the subcellular sarcomere units to the entire organ, must be extremely 
well optimized for efficiency in its singular role to pump blood. Incredibly, the heart is also 
capable of adaptation to variations in blood pressure and flow, oxygen demand, or other 
external stimuli, allowing for large changes, acutely or chronically, in heart rate, developed 
pressure, and even myocyte geometry to compensate for variations in environmental 
properties, e.g. demand or downstream resistance. 
Because of the high demands placed on the heart and its vital importance to 
maintaining life, perhaps it is not surprising that diseases of the heart and cardiovascular 
system continue to be the primary cause of death in the United States [1]. This fact, together 
with the aging of the population, indicates that it is imperative to better understand the 
diseases of the heart, specifically the structural and functional changes that occur during 
disease, as well as the mechanisms by which those changes occur. Such an understanding will 
enable clinicians to better treat those with cardiovascular disease to improve function and 
quality of life, as well as provide opportunities to improve preventive care, especially for 
younger generations. 
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To those who have studied the tissue structures of the heart in detail, it becomes 
obvious that the myocardium is spatially non-uniform. Many have studied these spatial 
heterogeneities and have concluded that such regional variations are necessary to allow for the 
highly efficient pumping action of the heart. However, it is unclear what role these regional 
variations in structural features play in the progression of common diseases of the ventricle. 
It is with these considerations in mind that I, with the aid of many others, undertook to 
investigate the structural and functional changes that occur in animal models of two of the 
most common diseases in the left ventricle: pressure overload hypertrophy and myocardial 
infarction. 
1.1. Introduction to Regional Gradients 
The motion of the ventricular walls during normal cardiac pump function is highly 
complex, involving the coordinated activation and contraction of electromechanically coupled 
myocytes, followed by relaxation, and refilling. Despite numerous studies attempting to 
describe and model cardiac biomechanics, significant gaps of knowledge remain regarding the 
mechanisms by which cross-bridge force generation and sarcomere shortening are integrated 
by the hierarchical intracellular and extracellular organization of the myocardium and the 
anatomy of the chambers to produce the driving pressures for blood flow through pulmonary 
and systemic circulations. These gaps in knowledge represent potential opportunities for 
generating therapies or treatments for widespread cardiac disease, which remains the primary 
cause of death in the United States [1]. Hence, it remains of central importance to study the 
structure-function relationships that determine myocardial mechanics in the normal and 
diseased ventricles. 
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Much work has been done to quantify the three-dimensional deformation patterns in 
the normal left ventricle (LV) by tracking myocardial tissue during relaxation and filling 
(diastole), as well as during contraction and ejection (systole). Likewise, efforts have been 
made to characterize the internal tissue forces (stresses), with experimental measurements and 
mathematical or computational models. These studies have brought to light the complexity of 
normal cardiac mechanics, including insights regarding the mechanisms by which shortening 
along the axis of the myocytes drives circumferential and longitudinal shortening in the tissue, 
with concordant wall (radial) thickening and chamber torsion, to efficiently eject blood during 
systole, as well as the reverse process during diastole. 
One notable feature that has been described is the surprisingly homogeneous 
transmural distribution of fiber strain and stress across the wall of the normal LV in several 
mammalian species, including humans. Because simple mechanical theory of thick-walled 
pressure vessels predicts transmural gradients of strain and stress, with higher levels in the 
subendocardium, researchers have sought to understand how this uniformity (which is an 
optimal design principle in engineering) is achieved in the normal heart. Studies have shown 
many structural and functional features of normal LV myocardium that have transmural 
gradients, that may contribute to maintaining uniformity of fiber stress and strain during LV 
ejection and filling. Alterations in these structure-function relationships could contribute to 
adverse remodeling and ventricular dysfunction in heart disease, particularly in load-mediated 
remodeling processes such as cardiac hypertrophy. 
In this chapter, we review studies of transmural gradients of myocardial structure, and 
how variations in regional architecture affect transmural distributions of strains and stresses in 
the myocardium. In particular, we aim to summarize the mechanisms by which the structural 
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features that exhibit a transmural gradient may contribute to uniformity of fiber strain and 
stress, and how these distributions may change during disease. During remodeling processes 
in which mechano-sensing and mechano-transduction are important, understanding 
mechanisms that regulate the distributions of stress and strain will help define interventions 
aimed at altering the course of detrimental myocardial remodeling. We focus on examples 
related to mechanical regulation of concentric hypertrophy due to pressure overload, noting 
the high prevalence of hypertension, with one in three adults in the U.S. alone having high 
blood pressure [1]. 
1.2. Fiber Strain and Stress 
1.2.1. Fiber Strain 
While metrics of whole heart function such as ejection fraction, cardiac output, or wall 
thickening are informative and useful, especially for clinical classification of patients, the 
measurement of intra-myocardial deformation within the ventricle wall is imperative to fully 
understand regional mechanical function in myocardial tissue, and how load/deformation-
related mechanisms of remodeling could be affected by regional variations in mechanics. 
Since consistent anatomic material landmarks are not readily detected in myocardial tissue, 
specialized techniques for imaging and recording the displacement of material points within 
the myocardium have been developed and used to quantify mechanical strain. 
The measurement of strain within the ventricle walls has been achieved for decades 
using various techniques. In general, direct measurement of mechanical strain requires 
tracking of material points/markers in the tissue. Early, invasive studies involved the 
implantation of strain gauges, needles, radiopaque beads, ultrasonic crystals, or other markers 
whose positions were tracked in time [2]–[28]. Non-invasive methods have become more 
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available in animal models and humans, such as speckle tracking echocardiography [29], 
strain rate magnetic resonance imaging (MRI) [30], and tagged MRI [31]–[40]. MRI tagging 
is a technique whereby regions of myocardium are “tagged” with patterns of magnetization 
for a limited time as they deform through the cardiac cycle, thus enabling tracking of material 
point locations and strain calculations. The advantages of using tagged MRI include its non-
invasiveness, relative ease of use, and comprehensive coverage of the ventricles at relatively 
high resolution. Difficulties include potentially low signal to noise ratio and the challenge of 
converting data from 2D tagged images to 3D displacements, which has been addressed in 
various ways [31], [34], [40]–[42]. Despite these few challenges, tagged MRI with harmonic 
phase material point tracking is one of the best methods for a full 3D description of tissue 
deformation [34], [43]. 
To completely describe three-dimensional deformation in a given volume, the six 
unique components of the strain tensor are necessary, which can be defined with respect to 
any chosen coordinate system. Some natural reference frame options which have been used in 
the heart include “cardiac coordinates”, which locally correspond with circumferential, 
longitudinal, and radial directions of cylindrical or prolate spheroidal systems, “fiber 
coordinates”, in which the circumferential direction from cardiac coordinates is rotated by the 
fiber angle to align with the local myofiber direction resulting in fiber, cross-fiber, and radial 
directions [27], and “material coordinates”, which align with local fiber, sheet, and sheet-
normal directions [6]. The latter two systems allow for quantifying strain aligned with the 
fiber axis, which is parallel to the long axis of the myocytes, and therefore the direction along 
which sarcomeres shorten during systolic contraction.  
 6 
The strain tensor describes shape change between two time points or states. Fiber 
strain measured with respect to the unloaded state in passively loaded isolated arrested hearts 
or measured in vivo at end-diastole, with respect to early diastasis, has been used to 
investigate resting tissue mechanics. End-systolic fiber strain in vivo, usually referenced to 
end-diastole, characterizes the regional systolic mechanics of the myocardium. Using the 
above-mentioned techniques, researchers have sought to characterize fiber strains in the LV at 
end-diastole and end-systole to better understand how fiber mechanics relate to pump function 
and remodeling. 
End-diastolic fiber strain 
End-diastolic fiber strain gives insight into the passive material properties of 
myocardium, and describes the state of the sarcomeres at the moment of electrical activation. 
McCulloch et al. [17] used radiopaque markers and biplane radiography to measure epicardial 
end-diastolic strains with respect to an unloaded state (i.e. LV pressure 0) in dog and found 
that epicardial stretch during passive loading is greatest along the axis of the fibers. The same 
authors in a subsequent study suggested that the consequent torsional shear strain may serve 
to minimize transmural gradients of fiber lengthening during filling [44]. 
Omens et al. [21] measured transmural end-diastolic strains with respect to an 
unloaded state in the canine left ventricle. A major finding of that study, that corresponded 
well with previous studies of systolic strain [26], [27], was that the end-diastolic principal 
strain axis did not vary nearly as much with the wall depth as the fiber orientations, and 
increased in magnitude toward the endocardium. Given the gradient in the orientations of the 
myofibers across the wall, this result indicated that the maximum principal end-diastolic strain 
aligned closely with the subepicardial fibers, but was roughly orthogonal to the 
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subendocardial fibers, such that the subepicardial fiber orientation was the axis of maximum 
passive lengthening, but the subendocardial fibers were aligned with the axis of minimum in-
plane strain. To examine this more directly, they used measured myofiber orientations in the 
tissues at the regions of the markers to resolve the strains with respect to fiber, cross-fiber and 
radial axes. They found that fiber strain at end-diastole is strikingly uniform across the wall, 
whereas the radial and cross-fiber strain components displayed transmural gradients [21] with 
significantly higher magnitudes on the endocardium than epicardium. This uniformity of fiber 
strain at end-diastole has also been shown in other in-vivo studies including the rat [22] and 
dog [45]. End-diastolic fiber strain measured in these studies ranged from 0.05 to 0.15 at 
pressures of ~1.0 kPa up to ~0.2 at 2.4 kPa. 
As early as 1982, mathematical models of the left ventricle were used to test how 
transmural fiber angle variations and ventricular torsion affect transmural strain (and stress) 
distributions [46]. Simplified geometric models of the LV with spherical, cylindrical, and 
prolate spheroidal geometries, and anisotropy due to fiber orientation, have demonstrated 
uniformity in fiber strain across the wall at end-diastole with respect to an unloaded state [13], 
[47]–[49]. In agreement with the above experiments, end-diastolic strain values in these 
models were uniform and approximately 0.05-0.15 at 1.0 kPa filling pressure. 
End-systolic fiber strain 
Whereas measurements of fiber strains at end-diastole are necessary to describe 
myocardial passive mechanics, distributions of fiber strain at end-systole are key to 
understanding systolic pumping mechanics. Fenton et al. [11] were among the first to measure 
transmural systolic strain distributions using implanted radiopaque beads as material markers. 
They did not measure fiber orientations, but their results suggested mostly uniform end-
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systolic fiber deformation. Many experiments following this approach have carefully 
quantified transmural fiber strain, including those in which the fiber orientations across the 
wall were measured by histology in the same region of the systolic strain measurement in dog 
and sheep LV [3]–[6], [27], [45]. In every case, fiber strains at end-systole with respect to 
end-diastole were found to be quite uniform transmurally, with values typically around -0.1 
(i.e. about 10% fiber shortening) in each case in open-chest anesthetized animals. 
Biplane radiography of implanted radiopaque markers is quite invasive, and therefore 
not typically feasible in humans, though it has been done in donor hearts received by heart 
transplant recipients [28]. A more feasible, non-invasive approach to regional strain recording 
in-vivo was developed using cardiac MRI [33], [35]. Experiments using these non-invasive 
approaches, including MRI tagging for material point tracking, have found that transmural 
fiber strain is uniform at end-systole with respect to end-diastole in several animal species and 
humans [36], [38]. The values of these measured end-systolic fiber strains are typically in the 
range of -0.1 to -0.2, corresponding to a uniform fiber shortening of about 10-20%. 
Several models were developed to aid in the description of fiber strains during active 
contraction of the myocardium (systole), most often at end-systole, with end-diastole or an 
unloaded configuration as the reference phase. Early models, using a cylindrical shape for the 
LV, showed that fiber strain was uniform at end-systole [2]. This result was confirmed by 
modeling multiple fiber angle distributions in an ellipsoidal model [50], in a more realistic 
geometry of dog LV [13], and by iterative optimization of the fiber angle, which matched 
previously published measurements [51], [52]. 
A major result that surfaced from these models of myocardial mechanics is that 
anisotropy, fiber orientations, and the resultant torsion are key elements of myocardial 
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structure in the development of homogeneous fiber strain distributions across the wall. The 
myocardium is stiffer in the fiber direction than in the cross-fiber direction, and the direction 
of torsion is the same at both the epicardium and endocardium. Since torsion is essentially a 
shear in the circumferential-longitudinal plane, in which the fibers lie, it acts to increase the 
stretch of epicardial fibers during filling. Conversely the same torsion on endocardial fibers 
reduces fiber stretch during diastole. During systole these mechanisms are reversed, 
increasing fiber shortening in the subepicardium and decreasing it in the subendocardium. 
These important features will be discussed in greater detail in section 1.3 below. 
With these key mechanisms accounted for, the consistent result of these experiments 
and mathematical models has been that fiber strain at end-systole is transmurally uniform, at a 
value of approximately -0.10 to -0.20, corresponding to about 10-20% fiber-aligned segment 
shortening from end-diastole. 
1.2.2. Fiber Stress 
The direct experimental measurement of stress within the myocardium is extremely 
challenging, especially while preserving native tissue structure and function, although some 
groups have attempted to implant stress sensors to achieve this, with limited success [53]–
[55].  However, the development of computational tools such as finite element modeling, and 
the measurement and optimization of tissue material properties ex vivo [56]–[60] provide 
probably the best approach to estimate regional and 3D stresses given a set of reliable strains 
[61], [62]. A large number of such models have been developed to better understand regional 
cardiac mechanics [63]. 
End-diastolic fiber stress 
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Early models of end-diastolic stress distributions by Beyar and Sideman report 
circumferential stress rather than fiber stress, but do note that allowing torsion in their prolate 
spheroidal model reduced the heterogeneity of wall stress at end-diastole [64], [65]. 
Understanding true fiber stress, however, requires measurement of fiber orientations across 
the wall. One of the first modeling studies that reported end-diastolic fiber stress in models of 
rat and dog LVs under passive inflation showed relatively uniform fiber stresses, especially in 
the rat (~1 kPa), but less so in dog (2-9 kPa) [22]. Other models of end-diastole confirmed 
transmural uniformity of fiber stress in cylindrical models with papillary muscles and valves 
[66], radially symmetric canine LV geometry [13], and prolate spheroids of varying sphericity 
[47], though still others reported a less uniform distribution in spherical, cylindrical, and 
prolate geometries [48], [49]. The reported fiber stresses were approximately 1.9-2.5 kPa at a 
filling pressure of 1.0 kPa. In general, the stress distributions follow strain distributions, but 
several factors and mechanisms can alter this relationship as described in more detail below. 
End-systolic fiber stress 
As early as 1970, models were developed to quantify stresses at end-systole based on 
the measured distribution of fiber angles in the LV [67]. In this model, it was assumed that 
fiber stresses during systole were uniform across the wall (~20 kPa), then circumferential and 
longitudinal stresses were compared with those obtained from direct measurement, which 
agreed closely. Subsequently, models wherein fiber stress and strain were calculated found 
strong uniformity in end-systolic (and end-diastolic) fiber stresses and strains across the wall, 
as long as appropriate physiological fiber orientations were included [50], [66], [68]. A model 
with a more realistic geometry (though still radially symmetric), found strong uniformity of 
end-systolic fiber stress in the equatorial region, but a more heterogeneous distribution near 
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the base and apex [13]. In this model and others, end-diastolic and end-systolic in-plane (i.e. 
circumferential and longitudinal) strains matched measured data, but out of plane strain 
components (i.e. radial) generally did not. Modeling the myocardium as orthotropic, i.e. 
material properties corresponding to both fiber orientation and the laminar sheets of tightly 
coupled muscle fibers, with these sheets oriented roughly perpendicular to ventricular wall 
[69], improved the estimation of these out of plane strain components, but they still did not 
match directly measured strains [70]. Even recent computational models still cannot 
accurately predict all deformation and strain tensor patterns, even if bimodal sheet 
populations, which have been observed in animal studies [71], and whose supposed function 
has been modeled [72], are included (see e.g. [73]). This indicates a lack of understanding of 
the mechanical contribution of sheet structures to material strains. Despite difficulty in 
predicting radial strains due to the complexity of myocardial structure and contractile 
function, the majority consensus from these modeling studies has been that fiber stress at end-
diastole and end-systole is transmurally uniform. 
1.2.3. Mechanisms of Uniform Fiber Stress and Strain 
Overall, a consistent result from experiments and models is that fiber strain and stress 
are quite uniform transmurally both at end-diastole and at end-systole in the normal left 
ventricle. It is worth appreciating that classical engineering analyses of uniform thick-walled 
pressure vessels predict high stresses and strains on the inner surface [74], [75], with large 
transmural gradients. This is a natural consequence of deformation of an incompressible, 
homogeneous, thick-walled chamber under an internal pressure load. The endocardial 
circumference must increase more than the epicardial circumference during filling, and 
decrease more than the epicardial circumference during ejection, resulting in large transmural 
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gradients of stress and strain. Thus, in both phases of the cardiac cycle, the circumferential 
filling (diastolic) and ejection (systolic) strains are higher on the endocardium, and 
experimental measurements consistently show this behavior. How then, can fiber strain (and 
stress) be uniform, especially since similar arguments can be made for longitudinal strain 
distributions? 
The mechanisms leading to transmural uniformity of fiber stress and strain likely 
depend on specific transmural non-homogeneities in the myocardium. As mentioned 
previously and prominent among these is the fiber direction, which, along with chamber 
torsion, tends to normalize mechanical gradients. This has led several groups to propose that 
transmural uniformity of myocardial fiber stress and strain, and hence of regional myocardial 
work, is an important homeostatic principle of myocardial mechanics. It has been postulated 
that this uniformity may help maximize the efficiency with which regional contractile work is 
converted to pumping function and minimize vulnerability to ischemia or injury in systole 
[21], [44], [76]. All else being equal, this idea implies that there must exist one or more 
transmural gradient in tissue properties, architecture, or cellular characteristics that normalizes 
fiber stress and strain across the ventricle wall. In reality, several such transmural gradients 
have been observed that may explain this phenomenon. Here, we discuss measured transmural 
gradients from the literature, and how they may contribute to uniform fiber stress and strain. 
We also discuss effects of changes in these distributions during cardiac disease, with a focus 
on compensated concentric hypertrophy due to pressure overload. 
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1.3. Transmural Gradients as Mechanisms of Uniform Fiber Stress and Strain 
1.3.1. Fiber Angle and Torsion 
As previously mentioned, one of the most intriguing aspects of normal left ventricular 
function that has been observed for centuries is torsion or twist during the cardiac cycle. In the 
17th century, Lower [77] described this phenomenon during systole as the "wringing of a 
linen cloth to squeeze out the water", and it has since been well characterized [78]. During 
isovolumic contraction, the ventricle rotates counterclockwise when viewed from the apex 
[79]. During ejection, the base changes directions, rotating clockwise, while the apex 
continues its counterclockwise rotation. Studies have also shown that the heart untwists 
rapidly during early relaxation independent of any contractile activity [3], [80], [81]. Many 
studies have measured torsion using various techniques, with spatial modulation of 
magnetization tagged cardiac MRI being the gold standard, and speckle tracking 
echocardiography as a relatively new and potentially valuable clinical approach [82]. 
Interestingly, a transmural gradient of torsion appears to exist, with endocardial rotations 
being greater at apex, mid, and basal levels than epicardial rotation [33], [39], [83], [84]. 
The muscle fiber architecture in the mammalian left ventricle is the fundamental cause 
of torsion. Since the histological studies of Streeter and colleagues in the 1960s [85] it has 
been appreciated that the orientation of myofibers in the left ventricle changes gradually from 
a left-handed helix with a pitch of 50-80 degrees on the epicardium, to a right-handed helix 
with a pitch of 60-90 degrees on the endocardium, with a smooth, nearly monotonic variation 
in between. Subsequent studies have verified this fiber architecture, and many have shown 
that it can be detected via Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) [86]–
[88]. 
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Of the reports mentioned previously, several models were employed to understand the 
influence of fiber angle distribution on LV mechanics. It was found that stresses and strains 
were highly sensitive to the fiber orientation distribution [50]–[52], [89], [90]. It has also 
recently been proposed that torsion may be important in stress sensing, which may help to 
protect the heart from injury due to excessive stresses [91]. 
Because of the thick-walled shape of the left ventricle, the epicardial tissues have a 
larger radius from the LV center, and thus a greater lever arm during contraction-induced 
torsion. If all the fibers across the wall were aligned with the same helical pitch, then this 
contractile force in the epicardium would obviously necessitate more shortening in the 
endocardium. However, because the helical pitches are opposite (approximately 120° 
separation) from epicardium to endocardium, shortening of the epicardium and its resultant 
torsion result in shortening in the cross-fiber direction in the endocardium. This allows the 
sarcomeres in the endocardial fiber direction to contract relatively independently from 
(orthogonal to) those of the subepicardium. 
It is apparent that the transmural fiber orientation gradient in normal hearts is 
important in dictating normal torsion and in normalizing fiber stress and strain across the wall. 
Perturbations to this fiber architecture could contribute substantially to altered cardiac 
function. Several studies have sought to determine if fiber orientations change during disease. 
An early study showed a decrease in fiber inclination angle only in the subendocardium in 
eccentric and concentric hypertrophy, though less so in concentric [92]. However, a later 
study reported more longitudinal fibers in pressure overload (concentric) hypertrophy and no 
change in exercise or volume overload (eccentric) hypertrophy [93]. Omens, et al. later found 
no difference in fiber angle in pressure overloaded rat hearts [94], [95]. However, fiber 
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orientations were measured in mice with left ventricular hypertrophy using DT-MRI, and 
slight but statistically significant differences in helix and inclination angles were found in the 
free wall and septum [96]. Also, the fiber orientation and dispersion in the right ventricle 
changed with pulmonary artery constriction [97]. 
For the most part, it appears that pressure overload hypertrophy minimally affects 
fiber angle distributions in the LV, though some small changes may occur. Together with the 
high level of conservation of this pattern in mammalian hearts, this fact suggests that the 
native fiber orientation is highly important and needs to be preserved in order to maintain 
normal cardiac function. 
1.3.2. Material Anisotropy 
Material anisotropy in most biological tissues is a direct determinant of local 
mechanical function. Myocardium is no different as it has a distinct fiber architecture, as well 
as laminar sheets that create a mechanically and electrically orthotropic material wherein 
fiber, sheet, and sheet-normal directions and function can be defined at any location in the 
ventricle wall [69], [70], [98]–[100]. Early biomechanical and electrophysiological modeling 
studies assumed transverse isotropy, however, several invaluable biomechanics studies have 
shown that ventricular tissue is in fact orthotropic [56], [57], and these directional properties 
related to fiber and sheet architecture play a significant role in determining tissue stress and 
strain. 
Biomechanical experiments by Humphrey and Yin showed that the anisotropy of 
myocardial tissue may vary as a function of wall depth [60], [101]. Novak, et al. [57] later 
demonstrated that while myocardial tissue anisotropy is qualitatively uniform (i.e. the form of 
anisotropy does not change) in the canine left ventricle, it is quantitatively different between 
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epicardium and mid-myocardium. Lin and Yin [102] also showed that the material properties 
of active myocardium are different than that of passive myocardium, and are of course 
anisotropic, with significant development of cross-fiber stresses during contracture. Most 
recently, Sommer, et al. have shown the orthotropic mechanical properties of human 
myocardium [103], [104]. 
Arts et al. [105] showed the importance of anisotropy in their early models of LV 
mechanics, but the significance of the orthotropic nature (i.e. the sheet structure) of the 
myocardium has surfaced more recently [4]–[6], [72], [106]–[112]. Since it is commonly 
argued that sheet structures contribute to wall thickening by allowing large shear 
deformations to occur [4], [6], the orientation, dispersion, and mechanical properties of these 
sheets are undoubtedly important factors contributing to fiber stress and strain. The 
conduction of the electrical signal along the sheets is faster than across them, so timing of 
contraction is also affected by sheet structures [113], which in turn also affects regional 
stresses and strains [114]. 
Pressure overload induces hypertrophic remodeling of the extracellular matrix (ECM) 
by fibrosis (increase in collagen content) and collagen remodeling by fibroblasts [115]–[118]. 
Since the ECM is a major load-bearing component of cardiac tissue, fibrosis directly affects 
passive tissue properties [119]–[122]. Additionally, disorder of sheet structures has been 
measured in hypertensive heart disease [123]. The implications of this reorganization of sheet 
structures combined with fibrosis, mechanical stiffening, and other forms of remodeling on 
tissue mechanics require further study. Nonetheless, collagen content and remodeling and 
fiber and sheet reorganization undoubtedly alter tissue anisotropy and the distribution of fiber 
stresses and strains. 
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1.3.3. Residual Stress 
Another potential mechanism contributing to uniform fiber stress and strain is that 
ventricular tissue is residually stressed (i.e. the unloaded, resting ventricle has internal 
stresses) and that the observed residual stress is non-uniform transmurally. Omens and Fung 
[124] first examined residual stress and strain in the rat LV following similar approaches used 
in other tissues, such as blood vessels [125]. Residual stress in cylindrical or spherical vessels 
is known to reduce stress concentrations at the inner surfaces, and this same mechanism is 
thought to occur in biological tissues. In the heart, it was found that making a radial cut in an 
equatorial cylindrical slice of rat left ventricle relieves circumferential residual stress, and 
results in an “opening angle” of approximately 45˚ [124]. This suggests that resting, unloaded 
ventricular tissue supports internal, residual stresses. It was shown that this residual stress is 
regionally variable as expected for the geometry of the ventricle, with endocardial residual 
stress being compressive, whereas epicardial residual stress is tensile. This work was later 
extended to show a linear transmural gradient in sarcomere length that becomes uniform when 
residual stress is released by a radial cut in the rat LV [126]. Similar results were observed in 
chick embryo [127] and dog [128]. Subsequent studies showed that 3D residual stress was 
even more complex with functional implications for distributions of normal and shear stresses 
during inflation [129]. 
Since normal, resting ventricular myocardium is residually stressed in this manner 
(with compressive stress in the subendocardium and tensile stress in the subepicardium), it is 
reasonable to postulate that fiber stress and strain are normalized by residual stress. Indeed, a 
cylindrical model showed that residual stress, together with anisotropy and torsion, normalize 
fiber stresses transmurally during filling [89]. Rodriguez et al. [126] commented that 
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Starling’s law likely works in combination with shortening deactivation and force-velocity 
relationship effects to normalize fiber stresses during systole, and that end-diastolic sarcomere 
length is likely the primary factor that determines developed tension. 
Residual stress has been shown to change in biological tissues due to external pressure 
overloads [130]. It was postulated that residual stress would increase under pressure overload 
hypertrophy [131]. Residual strain of the pressure overloaded left ventricle has been measured 
in rat [95] and chick embryo [132]. No significant difference in the opening angle was 
observed in rat, despite the reasonable hypothesis that it would increase with cell cross-
sectional area [95]. Similarly, chick embryo opening angles did not change or even decreased 
[132]. Although residual stress has not clearly been shown to change with hypertrophic 
remodeling in the heart, residual stress does change in other cases such as extra-cellular 
matrix disease [133] and with normal cardiac growth [134]. With increased wall thickness 
without chamber dilation in pressure overload, residual stress is likely maintained in the 
tissue, indicating that the distribution of residual stress may be important for regulating fiber 
mechanics in both diastole and systole. 
1.3.4. Protein Densities 
In addition to tissue-scale properties that can modulate stress and strain gradients in 
the ventricles, molecular-scale distributions and gradients of structural and functional proteins 
in myocytes and ECM may contribute to uniformity of fiber stress and strain by modulating 
individual myocyte electromechanical functions, and the interplay between cells and the 
supporting ECM. Many of the reports summarized in the following sections describe 
heterogeneous protein distributions in the ventricles, with implications for active and passive 
function, as well and long-term remodeling in response to altered external loading conditions.   
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We review here several such proteins with transmural gradients that could affect fiber stress 
and strain distributions, mechanisms by which they might do so, and how disease-induced 
remodeling of those distributions may alter fiber stress and strain. 
Passive structural proteins 
Collagen 
Collagen is a key structural component of the ECM and is therefore important in 
determining the passive mechanical properties of myocardial tissue [120], [135]. Collagen 
type I is predominant in the ventricles, and although its volume fraction is unchanged as a 
function of wall depth in rat LV, the form that collagen takes varies from subendocardium to 
subepicardium, in that the sheet structures mentioned above are clearly defined in the 
subendocardium and midwall, whereas toward the epicardium, collagen takes the form of 
longitudinal (parallel to the myocytes) cords [112]. This implies that the form and 
organization of collagen, rather than its content, may play a dominant role in terms of its 
transmural functional effects [136]. In Figure 1.1, collagen content is shown as uniform 
transmurally, with the implied understanding that the form is non-uniform. 
Fibrosis is a well-documented remodeling response during pressure overload [115], 
[119], [137]–[139], and will certainly affect stress and strain distributions in this type of 
remodeling. Although the exact micromechanical-based contributions of ECM components 
and structure to the anisotropic passive material properties of myocardium in normal and 
fibrotic tissue are still mostly undefined, the form, distribution, and advanced glycation end-
product mediated cross-linking of different types of collagen each can modulate cardiac 
stiffness [120]–[122], [140], [141]. Thus, it is reasonable to expect collagen/ECM remodeling 
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to modulate diastolic mechanics, possibly with regional variations due to the 3D laminar sheet 
architecture in the ventricular walls.  
Titin isoform 
Titin also represents a major component of passive mechanical properties in the 
cardiomyocytes. Two major isoforms, N2B and N2BA, are found in cardiac muscle. The 
shorter isoform, N2B, is stiffer than the larger N2BA isoform, and is predominant in human 
hearts [142]. Species-specific differences in the N2BA:N2B ratio exist, and it is thought that 
changes in this ratio modulate myocyte stiffness, where a higher ratio of N2BA:N2B 
corresponds with more compliant tissue, and vice versa [143]. Additionally, a transmural 
gradient of the N2BA:N2B ratio was observed in pig and canine hearts where a higher 
N2BA:N2B ratio exists in the subendocardium than in the subepicardium [80], [144]. Cazorla, 
et al. speculated that inter-species variations in cell-to-cell stiffness is related to strain 
normalization of myocytes in different regions of the ventricular walls [144]. This is 
consistent with the fact that the endocardial layer deforms more during a normal heart beat 
than the epicardium. The transmural gradient in the titin isoform ratio could suggest that 
stiffness along the fiber axis may also vary transmurally, leading to altered regional diastolic 
anisotropic material properties. 
It has been shown that the N2BA:N2B ratio is decreased in spontaneously 
hypertensive rats [145], and in human patients with aortic stenosis [142], both of which are 
forms of pressure overload. In hearts that underwent two weeks of pacing tachycardia, the 
transmural gradient in titin ratios was exaggerated, and was postulated to contribute to a 
reduction in restoring forces after systolic contraction [80]. The changes to this isoform ratio 
in pressure overload need to be further examined, as well as the functional implications 
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postulated by the resultant changes in muscle stiffness. It is possible that this ratio is 
modulated to offset fibrotic stiffening during disease in order to maintain ventricular 
compliance and/or contractility. 
Active sarcomere dynamics proteins 
Myosin Regulatory Light Chain Phosphorylation 
Myosin light chain (MLC) phosphorylation via myosin light chain kinase (MLCK) has 
been shown to increase the sensitivity of MLC to Ca2+, and is therefore a key determinant of 
tensile force produced in myofibers [146], [147]. Davis et al. observed a transmural gradient 
of phosphorylated regulatory light chain in normal mouse left ventricle, with increasing levels 
of phosphorylation from endocardium to epicardium [148]. They postulated that this gradient 
was required to facilitate normal LV torsion. Additionally, double mutant mice, in which 
MLC cannot be phosphorylated, had decreased performance and an eccentric hypertrophy 
phenotype with decreased LV torsion [149]. This study confirmed that MLC phosphorylation 
facilitates LV torsion, a key component of normalizing fiber stress and strain.  
The latter study also proposed that phosphorylation of MLC is indispensable in 
regulating actin-myosin crossbridge dynamics and plays an important role in heart failure 
[149]. Toepfer, et al. also demonstrated that increased phosphorylation in rat trabeculae 
enhanced myocardial performance and suggested that decreased MLC-phosphorylation in 
cardiac disease is a key contributor to impaired cardiac contractile function [150]. MLC 
phosphorylation levels were significantly reduced in pressure overloaded and failing hearts 
[151], but heart failure was prevented in MLC kinase-overexpressing mice [152]. 
Additionally, constitutively phosphorylated cardiac MLC in mice was sufficient to prevent a 
hypertrophic cardiomyopathy phenotype [153], [154]. Conversely, knockout of MLC induced 
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heart failure [155]. These studies highlight the importance of MLC phosphorylation, including 
its transmural gradient, in the development of normal LV torsion and contraction, and a 
possible role in heart disease. 
Myosin Heavy Chain Isoform 
Myosin heavy chain (MHC) forms the head/neck region of the myosin crossbridge. 
Two major isoforms exist with different functionality. The α isoform (MHC- α) is faster and 
stronger but less energy-efficient than the β isoform (MHC-β). MHC-β is predominant in 
human hearts, whereas MHC-α is more highly expressed in rodents. Stones et al. measured a 
transmural gradient in MHC-β mRNA in rat LV, with more found in subendocardium than 
subepicardium [156]. No gradient in MHC-α was found in rat ventricular myocytes [157], but 
it has been shown in porcine hearts that greater expression in MHC-α isoform expression in 
the subepicardium contributes to differing mechanical function and timing, both of which may 
modify fiber stresses and strains [158]. Specifically, epicardial fibers were activated and 
developed force at higher rates than endocardial fibers. It is likely that the faster and 
supposedly stronger contraction of the MHC-α isoform will result in increased compressive 
stresses and strains in the fiber direction than that of the MHC-β isoform. This difference in 
the timing and rate of force production between epicardial and endocardial myocytes 
therefore is likely a major contributor to the distribution of fiber stresses and strains. 
In small rodents, shifts in isoform expression toward MHC-β are associated with 
cardiac disease, including hypertrophy and failure [159]–[161]. This may suggest that 
cardiomyocytes attempt to improve their efficiency during increased workload demand, but 
some have reported that this shift may be maladaptive [160]. Regardless, even small changes 
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in MHC isoform levels during hypertrophic or other remodeling will likely contribute to 
altered LV functional mechanics by regulating the timing and force of contraction [159]. 
Electrophysiological proteins 
Ito Proteins: KChIP/Kv4.2/Kv4.3 
A well-known feature of myocardium is the difference in action potential duration 
(APD) across the wall, which, together with the activation sequence results in a positive QRS 
complex and a positive T-wave of the ECG [162]. This transmural gradient in APD is in part 
due to the transient outward potassium current (Ito). This current is comprised of contributions 
from Kv4.2, Kv4.3, and KChIP proteins. Interestingly, Kv4.2 but not Kv4.3 showed a 
transmural gradient in rat LV [163]. Similarly, there was only a slight gradient in Kv4.3 found 
in mouse, compared to more marked gradients in Kv4.2 and KChIP [164]. Canine and human 
LV showed no gradient in Kv4.3 but a significant gradient in KChIP [165], [166]. The KChIP 
and Kv4.2 expression patterns almost universally had higher levels in epicardium than 
endocardium. These gradients explain the observed phenomenon of differing APD across the 
wall [167]. 
The Kv4.2 protein is a subunit of voltage-gated potassium channel in cardiac 
myocytes, partially responsible for generating the Ito during the early plateau phase of the 
action potential, wherein Ca2+ ions are released and bind troponin C to initiate contraction. In 
rat, human, dog, and other mammals, Kv4.2 is denser in subepicardium than subendocardium. 
It is well known that endocardial cells are typically activated earlier than epicardial cells, and 
that the duration of the action potential in endocardial cells is longer than that of epicardial 
cells, so that they are repolarized after their epicardial counterparts. One of the potential 
reasons for this is the greater concentration of Kv4.2 in epicardial cells, which are responsible 
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for phase 1 early repolarization of the action potential in these cells. The early repolarization 
phase of the action potential is nearly nonexistent in subendocardial myocytes. This suggests 
that the endocardial myocytes are activated for a longer period of time than epicardial 
myocytes in the same heartbeat. Thus, the potential exists for more cross-bridges to be 
activated and to a greater extent. This would imply that higher strains (and stresses) may exist 
in the subendocardium due to this electrophysiology-based mechanism. 
Wang et al. confirmed the native gradient in Kv4.2 in mice, and found that pressure 
overload reduced subepicardial Kv4.2 levels and current, eliminating the transmural gradient 
found in normal mice [168]. Thus, action potential-mediated myocyte function could play a 
role in hypertrophic remodeling. 
Kcnk2 (TREK-1) 
The potassium channel subfamily K, member 2 (Kcnk2), or 2-pore domain potassium 
channel TWIK-related K+ (TREK-1) has been extensively studied, and is thought to modulate 
the APD regionally and during sympathetic activation [169]. The TREK-1 gene, mRNA, and 
protein expression levels were greater in endocardial cells than epicardial cells [156], [170]–
[172]. Interestingly, the gradient of this potassium channel is in the opposite direction to that 
of the Kv4.2 and KChIP channels, all of which contribute to repolarization, though with 
differing kinetics they are responsible for acting during different portions of the action 
potential [173], [174].  
In hypertrophy, the levels of TREK-1 increased everywhere, such that the normal 
transmural gradient was maintained [172]. Similar to the discussion for the Ito proteins above, 
this protein’s expression level is important in determining the sequence of activation and 
deactivation, and can thus impact regional stress and strain by impacting regional APD. 
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Connexins (Cx43) 
Another important determinant of electrical conduction through cardiac muscle tissue 
is its anisotropy, which is dictated in part by the presence of gap junction channels, which 
primarily localize to the ends of the long, rod-shaped myocytes, reducing resistance to 
electrical conduction along the fiber direction. Connexin plaques are also found coupling 
adjacent cells, contributing to lateral propagation of activation [175]. The presence of the 
sheet structures makes this conduction orthotropic [113]. In ventricular myocytes, gap 
junctions are primarily formed by connexin-43 (Cx43). Yamada et al. found transmural 
gradients of Cx43 in the mouse LV, with a greater abundance in the subendocardium and 
mid-myocardium than subepicardium [176]. This pattern, however, was not observed in rat 
LV. A similar pattern to that in the mouse was seen in dog [177] and rabbit [178]. It is not 
straightforward to draw a connection between increased Cx43 expression and fiber strain, 
especially considering that expression may not necessarily influence conduction velocity per 
se. The use of finite element modeling of electromechanics in the ventricles with regionally 
variable fiber conduction would therefore be a useful study to help define the role of this 
transmural gradient for regional mechanical function. 
Poelzing and Rosenbaum also showed that Cx43 expression is significantly reduced 
uniformly in dogs with heart failure, such that the gradient observed in normal dogs was 
preserved [179]. In humans with aortic stenosis, connexin-43 amounts increased during 
compensated hypertrophy, then decreased during decompensated hypertrophy [180]. An 
important feature of Cx43 remodeling during disease, including pressure overload and MI, is 
that of lateralization, which undoubtedly affects conduction anisotropy and velocity [180]–
[183]. The effects of such remodeling on electromechanics require further study. 
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Calcium handling proteins 
SERCA2a 
The sarco-/endoplasmic reticulum calcium ATPase pump (SERCA2a) is a primary 
factor in removing Ca2+ ions from the cytosol following activation. Laurita et al. determined 
that more SERCA2a is expressed in the subepicardium than in the subendocardium in canine 
hearts, then showed using optical mapping how such differences may lead to altered 
activation patterns[184], [185]. Others confirmed this pattern in dog as well as both non-
failing and failing human hearts [186]–[188]. However, this pattern was not observed in rat 
[189]. 
Cordeiro et al. also showed a difference in calcium transients in epi-, mid-, and 
endocardial cells from canine hearts [190]. Their results suggested that differences in calcium 
homeostasis regulate synchronization of ventricular contraction across the wall, despite 
 
Figure 1.1. Summary of transmural gradients. 
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different electrical activation times. Computational models of these differences in Ca2+ 
dynamics within a finite element model of LV mechanics showed that this was not a factor in 
regulating end-systolic fiber strain, but that the effect of these gradients on fiber and cross-
fiber strains in the LV is most apparent at early systole, rather than end-systole [191]. Even 
so, SERCA2a activity has been shown to affect contractility and relaxation in disease [192], 
[193], and changes in regional distributions may play a role in mechanical function of the 
myocardium. 
In severe pressure overload, SERCA2a expression was decreased in the whole rat 
heart [194], [195]. This reduction in SERCA2a level was found to be nonhomogeneous 
throughout the LV [196], however the transmural pattern of SERCA2a decrease has not to our 
knowledge been reported. 
1.4. Summary and Conclusion 
A summary of transmural gradients described in this chapter is shown in Figure 1.1. 
Transmural uniformity of fiber stress and strain at end-diastole and end-systole appears to be 
a common finding from both experiments and mathematical models. Researchers have sought 
to understand the fundamental reasons for this homogeneity in function, postulating that 
uniform fiber stress and/or strain is likely important in improving ventricular pump efficiency. 
Several structural and functional factors in the normal myocardium that vary transmurally 
may be mechanisms contributing to the normalization of fiber stress and strain. In diseases 
such as pressure overload hypertrophy, several structural factors in myocytes and ECM may 
change, mediating the role of stress and strain in cardiac remodeling. The “holy grail” of work 
in this field would be to fully describe the contributions each transmural gradient to 
ventricular mechanics, and the mechanisms by which they do so. Computational modeling, in 
 28 
conjunction with continued experimental measurements, constitute a challenging but tractable 
method to accomplish those goals. 
1.5. Scope of the Dissertation 
The objective of this dissertation is to characterize the 3D, regional variations in 
structural properties and the associated functional behavior in the left ventricle in two major 
cardiac diseases: hypertension (pressure overload) and myocardial infarction. Experimental 
data were combined with computer models of left ventricular geometry derived from 
magnetic resonance imaging to discover novel regionally varying structural features and 
regional dysfunction in these major diseases. 
As described in Section 1.3.4 above, regional variations in protein densities affect 
regional mechanics and therefore left ventricular pump function. The first specific aim, 
therefore, is to determine the effect of pressure overload on regional distributions of 
electrophysiological and calcium handling proteins in the rat left ventricle. In this work, I 
showed novel significant regional gradients in protein densities and their redistribution in 
pressure overload. This information is valuable for generating computational models of 
ventricular mechanics and for identifying potential targets to reduce or reverse adverse 
remodeling in this prevalent disease. 
The second aim is to test the hypothesis that regional gradients in structural properties 
such as myocyte geometry are diminished in pressure overload. A secondary goal of this aim 
was to determine whether regional variations in these structural features could be 
comprehensively and non-invasively quantified using diffusion tensor MRI. In Chapter 3, I 
show using confocal microscopy that a transmural gradient in myocyte geometry in normal 
hearts was reduced in pressure overload, and that diffusion tensor MRI is sensitive to 
 29 
variations in structural features, regardless of whether those variations are due to regional 
heterogeneity or structural remodeling in pressure overload. This novel application of 
diffusion tensor MRI provides a faster, more comprehensive and non-invasive method to 
characterize tissue microstructure. Additionally, the measured regional variation in the 
remodeling response to hypertrophy is critical to understanding the functional effects of 
pressure overload and potential treatment options. 
Many researchers rely on two-dimensional echocardiography to quantify globally the 
extent of injury during myocardial infarction and therefore the efficacy of a treatment. 
However, this two-dimensional, global approach is insufficient to capture the spatial 
complexity of regional, three-dimensional structural and functional deficits accurately. 
Therefore, the third aim is to compare the measured size of a scar after myocardial infarction 
using traditional methods to the size of the corresponding region of dysfunction using a novel 
3D MRI-based approach. I show in Chapter 4 using this method that the region of dysfunction 
resulting from an infarction is significantly larger than the measured scar size, and this 
disparity increases with the duration of coronary blockage. This result indicates that a more 
comprehensive approach to understanding regional dysfunction in myocardial infarction is 
necessary and provides a straightforward method to do so. 
Spatial heterogeneity is a key feature of left ventricular structures. Researchers and 
clinicians must appreciate this 3D heterogeneity in order to better understand the functional 
effects of regional remodeling during disease and develop treatments to address remodeling to 
improve patient outcomes. 
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2. Regional Gradients of Calcium Handling and Sarcomere Activating Proteins in 
Pressure Overload Hypertrophy in the Rat Ventricles 
2.1. Introduction 
As has been detailed in Chapter 1, regional variations in tissue structures in the heart 
obviously play an important role in supporting and maintaining optimal regional and global 
function in the left ventricle, and the disruption of normal structural features likely contributes 
negatively to pump function. However, the interplay between the myriad structural features 
that exhibit such regional variation, and the contributions of each to the global pump function 
of the heart is not known. Computational modeling is one potential approach to study these 
interactions. Finite element modeling of the ventricles allows for defining physiology-based 
mathematical relationships that vary spatially across a discretized mesh and which contribute 
to the generation of stresses and strains [1]. Such modeling constitutes the best current 
approach to studying these interactions, however, they rely on accurate measurements of 
regionally varying structural features from experimentation, such as protein distributions. 
One such transmurally varying protein that has been previously described is the 
calcium (Ca2+) handling protein, sarco-/endoplasmic reticulum calcium ATPase (SERCA2a), 
whose primary function is to remove Ca2+ from the cytosol of myocytes after activation. As 
mentioned in Chapter 1, it has been shown that SERCA2a exhibits a transmural gradient in 
normal canine hearts, with more SERCA2a in the subepicardium (EPI) than the 
subendocardium (ENDO) [2]–[4]. This regional gradient was confirmed in human hearts but 
was not observed in the rat [5]–[8]. 
Ca2+ is the signaling messenger that is responsible for activating sarcomeric 
contraction in myocytes and is therefore an important component for maintaining normal 
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cardiac function. Considering this fact, and the previously described transmural distributions 
of tissue features such as myocyte geometry, electrical activation and repolarization, and more 
[9], [10], it is not illogical to predict that Ca2+ handling proteins may also exhibit a transmural 
gradient, especially given the evidence in favor of this pattern in other species. Additionally, a 
better understanding of regional Ca2+ dynamics could provide valuable insight as to how 
cardiac function is optimized in normal tissue and how it is affected in disease. Although it is 
clear from the literature that regional variations in structural features and protein density are 
present in the normal mammalian ventricles, most studies investigating remodeling during 
disease ignore the regional gradients described and assume that the changes in protein level 
are global. Therefore, a clear understanding of the regional changes in protein density in 
disease is lacking. 
We hypothesized that even if it is the case that SERCA2a does not exhibit a 
transmural gradient in the rat LV [8], other Ca2+ handling proteins such as phospholamban 
(PLB), the plasma membrane calcium ATPase (PMCA), or the sodium-calcium exchanger 
(NCX) vary transmurally to produce a similar functional effect in Ca2+ dynamics. We 
explored this hypothesis using western blotting (WB) and immunofluorescence microscopy 
on entire cross-sections of both ventricles from rats with four weeks of transverse aortic 
constriction (TAC) and sham controls (SHAM).  
As an exploratory experiment, we also investigated the regional variations in myosin 
light chain kinase (MLCK) and the gap junction channel protein connexin-43 (Cx43). 
Phosphorylation of myosin light chain (facilitated by MLCK) modulates the sensitivity of 
myosin light chain to Ca2+ and has been shown to vary transmurally in the mouse LV with 
higher levels of phosphorylation in EPI than ENDO [11]. Also, Cx43 levels were higher in 
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ENDO than EPI in mouse [12], dog [13], and rabbit [14], but not in rat [12]. Cx43 is 
important in maintaining normal electrical conduction and is known to remodel with respect 
to myocyte geometry in diseases such as heart failure [15], compensated hypertrophy [16], 
and myocardial infarction [17]. The balance of these transmural gradients are considered 
important mechanisms to maintain optimal cardiac function in the healthy heart. 
2.2. Materials and Methods 
2.2.1. Transverse Aortic Constriction (TAC) Surgery 
All procedures were performed in compliance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals and were approved by the Institutional 
Animal Care and Use Committee. A total of 22 male Sprague-Dawley rats (mean body weight 
= 210 ± 12 g) were randomly separated into two groups, SHAM (N=8) or TAC (N=14). 
Anesthesia was administered via inhalation of 1.25%-2.00% isoflurane and confirmed with a 
toe pinch. The chest was opened via lateral thoracotomy, and the aortic arch was exposed. For 
TAC animals, a hemo-clip was inserted between the right innominate and left carotid arteries 
and clamped down to a width of 0.5 mm, which constricted the aorta to approximately 60% 
the original diameter. SHAM controls underwent the same procedure, with the exception of 
clip insertion. The surgical incisions were sutured closed and the animal recovered normally. 
The clip remained in the animal until four weeks after the surgery date. M-mode 
echocardiographic data were obtained 1 day prior to the surgery, at two weeks, and at four 
weeks after surgery. 
2.2.2. Dissection into Regions 
At the four-week time point, the heart was excised, blotted dry, weighed, and placed in 
high-potassium Krebs-Henseleit buffer. Hearts were then dissected on ice as shown in Figure  
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2.1, described as follows: A cut was made inferior to the valve plane using a razor blade to 
isolate the ventricles from the atria. Ventricles were then separated into left ventricular (LV) 
free wall, septum (SP), and right ventricular (RV) free wall. The LV free wall was subdivided 
into two longitudinal sections – apex and base, and each of those were subdivided further 
transmurally into EPI, mid-myocardium (MID), and ENDO. The RV was also divided into 
two longitudinal sections (apex and base) but only two transmural sections (EPI and ENDO), 
and the SP was only divided transmurally into EPI and ENDO. The RV side of the SP was 
considered EPI. 
2.2.3. Protein Isolation 
Protein was isolated from these regions in the following manner. Tissue was placed in 
RNAlater (ThermoScientific AM7020) and stored at room temperature. Tissue was lysed with 
 
Figure 2.1. Regional dissection of the ventricles. Schematic illustration of the sectioning 
method used to divide ventricles regionally. 12 total regions were defined. The LV free 
wall was divided longitudinally into apex and base, then transmurally for EPI, MID, and 
ENDO. The RV was divided twice longitudinally (apex and base), and these were divided 
twice into EPI and ENDO. The SP was only divided transmurally into EPI and ENDO. 
 
 
 54 
a Knotes Duall # 20 glass Dounce homogenizer in RIPA lysis buffer (50mM Tris-HCl, 
150mM NaCl, 0.1% Sodium Dodecyl Sulfate, 0.5% Sodium Deoxycholate, 1% Triton-X 100, 
1X Halt Protease & Phosphatase Inhibitor Cocktail (78442 ThermoFisher Scientific) in Ultra- 
pure water). Cell lysates were vortexed three times for 15 seconds at maximum speed, rocked 
on ice for 15 minutes, centrifuged at 15,000 x g for 10 mins at 4°C. Supernatant concentration 
was determined by BCA assay (23235 ThermoFisher Scientific).  
2.2.4. Western Blot 
Measurements were performed with a standard Western Blot protocol using 
ThermoScientific Mini Gel Tank (#A25977), Bolt 4-12% Bis-Tris gels (such as 
#NW04125BOX), PVDF 0.2um pore size membrane (LC2002). Antibodies used from Santa 
Cruz Biotechnology: SERCA2a, 1:2000 (#sc-376235), NCX, 1:200 (#sc-32881), PMCA, 
1:100 (#sc-271917), PLB, 1:200 (#sc-30142). Antibodies from other vendors: glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), 1:10,000 (AbCam #ab9484), Connexin43, 1:8000 
(Sigma #C6219), MLCK, 1:5000 (AbCam #ab76092). Secondary antibodies used: Goat anti-
Mouse-HRP, 1:5000-1:100,000 (Sigma #A5478), Goat anti-Rabbit, 1:2500-1:3000 (Cell 
Signaling #7074), Donkey anti-Goat, 1:5000 (Novex #A15999). Western blot quantification 
was performed in ImageJ [18] (Figure 2.2). 
2.2.5. Data Analysis and Statistics 
All statistical comparisons between groups were performed in MatLab (The MathWorks, 
Natick, MA). Comparisons of measurements comparing TAC and SHAM groups are 
represented as mean ± SEM. Once raw data were acquired and compiled, protein levels were 
normalized to GAPDH or α-Actinin for each run. Analysis of variance (ANOVA) was 
performed for each protein investigated for the LV, RV, and SP, with intervention  
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 (SHAM/TAC), transmural position, and longitudinal position as factors, and total protein as 
the dependent variable. 
Only population marginal means and two-factor interaction effects were considered 
for this study. The percent difference of TAC levels vs. SHAM were computed for each 
region. Significance was defined as a p-value < 0.05, and for population marginal means, p-
values were corrected for multiple comparisons using the Tukey-Kramer method. 
2.2.6. Immunofluorescence Microscopy of Entire Ventricle Cross-Sections 
As an additional method to evaluate the normal regional variations in protein levels of 
Cx43 and SERCA2a in higher detail, we sought to generate a high-resolution map of 
immunofluorescence intensity in entire cross-sections of rat ventricles. A separate set of rats  
 
Figure 2.2. Representative western blot. Both MLCK and Cx43 were normalized to α-
Actinin. An obvious transmural gradient in Cx43 (~43 kDa) is observed in this sample. 
MLCK signal was lower overall than both Cx43 and α-Actinin. This may reduce the 
chances of observing a transmural gradient even if one truly exists due to higher variance. 
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of similar weight were anesthetized, and hearts were removed, blotted dry and weighed. 
Hearts were suspended and retrograde perfused with Krebs-Henseleit buffer until the tissue 
was cleared of blood and regular beating resumed. A modified Krebs-Henseleit solution with 
high potassium was then used to arrest the heart, and 4% paraformaldehyde in PBS was used 
to fix the heart in the slack state. The hearts were then dropped into 50 ml of 4% 
paraformaldehyde in PBS until sectioning. 
2.2.7. Tissue Sectioning, Staining, and Imaging 
Whole hearts were embedded in OCT (Leica Biosystems, Wetzlar, Germany) after 
ensuring that no residual fixative remained inside the ventricle chambers and that both were 
filled with OCT with no air bubbles. Samples were frozen and stored at -80°C until 
sectioning. Axial sections were acquired at 20-µm thickness through the length of the 
ventricles and mounted on glass slides. Primary antibodies used were as follows: Cx43 
produced in rabbit (1:2000, cat# SIGMA C6219, Sigma-Aldrich, Inc.); SERCA2a produced in 
mouse (1:200, cat# sc-376235, Santa Cruz Biotechnology, Inc.); α-Actinin (control) produced 
Table 2.1. ANOVAs for regional and group variation in protein density 
 
Main 
Region 
Test PLB PMCA NCX SERCA2a MLCK Cx43 
Overall 
Hyp 0.413 0.847 0.215 0.281 0.839 0.016 
Region <0.001* 0.405 <0.05* 0.593 0.227 0.077 
Hyp*Region 0.965 0.894 0.631 0.467 0.813 0.487 
LV 
Hyp 0.254 0.423 0.190 <0.01* 0.249 0.765 
Hyp*Trans 0.642 0.751 0.774 0.557 0.661 0.846 
Hyp*Long 0.485 0.430 0.109 0.992 0.687 0.788 
RV 
Hyp 0.615 0.216 0.410 0.246 0.148 <0.01* 
Hyp*Trans 0.430 0.572 0.378 0.960 0.725 0.193 
Hyp*Long 0.458 0.431 0.959 0.673 0.545 0.681 
SP 
Hyp 0.502 0.682 0.294 0.765 0.832 0.077 
Trans 0.483 0.131 0.186 0.518 0.082 0.033 
Hyp*Trans 0.629 0.420 0.210 0.522 0.202 0.700 
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in mouse (1:500, cat# sc-1506, Santa Cruz Biotechnology, Inc). Secondary antibodies used 
were goat anti-mouse conjugated with Alexa Fluor-488 secondary antibody (1:800, cat# 
A11029, Invitrogen, Inc.) or goat anti-rabbit IgG conjugated with FITC secondary antibody 
(1:500, cat# sc-2012, Santa Cruz Biotechnology, Inc). Only one primary antibody was used 
for each section. Sections were washed with PBS, permeabilized with 0.5% Triton X-100 for 
45 minutes at room temperature and washed again. Blocking was performed with goat serum 
(0.5%), with 1% bovine serum albumin (BSA) in PBS for 45 minutes at room temperature, 
and sections were washed again. Primary antibodies were diluted in 1% BSA in PBS and 
applied to slides overnight at 4°C. Slides were then washed again, and secondary antibodies 
(also diluted in PBS with 1% BSA) were applied for 1 hour at room temperature in the dark. 
After a final wash, Prolong Gold w/DAPI was applied, cover slips were placed carefully on 
the sample, and sections were dried shielded from light overnight. Slides were sealed with 
nail polish. 
Images were acquired using a Nanozoomer slide scanning microscope (Hamamatsu, 
Hamamatsu City, Shizuoka, Japan). A 20x objective with 0.75 NA was used to obtain 
brightfield and fluorescence images with Texas Red, FITC, and DAPI filters. Imaging 
parameters included the following: FOV: ~13mm×13mm, resolution: ~450 nm/pixel 
isotropic, resulting in a final image matrix of ~28,000×28,000. We observed strong 
autofluorescence in all channels and therefore attempted to reduce this effect using the Texas 
Red image. Although we attempted to quantify the data from intensity or density of punctate 
points (in the case of Cx43), this proved difficult and ambiguous, so the images herein are 
used only for a visual representation of the regional variation in protein densities. 
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2.3. Results 
2.3.1. Transverse Aortic Constriction (TAC) 
Consistent with the results from Chapter 2, at four weeks post-surgery, the systolic pressures 
in the ascending aorta were significantly elevated in the TAC group compared to SHAM 
controls (158±2 mmHg TAC vs 108±2 mmHg SHAM, p<0.0001). Animals in the TAC group 
were found to be in a state of compensated hypertrophy, with significantly higher HW/BW 
ratio (4.44±0.05 g/kg TAC vs 3.57±0.02 g/kg SHAM, p<0.01), and a significantly lower, yet 
still normal, (i.e. >50%) ejection fraction (80±1% SHAM vs. 73±5% TAC, p<0.01). 
 
 
Figure 2.3. Regional variation of Cx43. A consistent transmural gradient can be seen, 
with increasing Cx43 from EPI to ENDO, consistent with previous studies, though this 
effect only reached statistical significance in the SP region in the current study.  
(White = SHAM, Red = TAC) 
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2.3.2. Western Blot 
The major results of this study are summarized in Table 2.1 and Figures 2.3 - 2.6. In brief, 
the overall amount of Cx43 in the rat ventricles was 15% greater in TAC hearts compared to 
SHAM controls (p = 0.0163), but this effect was due mostly to large increases in the SP (57%, 
p = 0.077) and RV (64%, p = 0.006) regions, since in the LV (free wall), the total amount of 
Cx43 was not statistically different between the two groups (-4%, p = 0.765). The transmural 
gradient of Cx43 we observed was consistent between LV, RV, and SP, with increasing 
amounts of Cx43 from EPI to ENDO. However, this transmural gradient only reached 
statistical significance in the SP region (p = 0.037) (Figure 2.3). 
 
 
Figure 2.4. Regional distribution of SERCA2a The mean density of SERCA2a in the LV 
of TAC hearts was significantly lower than SHAM (-40%, p < 0.01). This difference was 
offset by slightly (not significant) higher values in the SP and RV of TAC hearts.  
(White = SHAM, Red = TAC) 
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In the LV region, SERCA2a was significantly lower in TAC hearts vs. SHAM (-40%, 
p = 0.002), although the effect of this difference over the ventricles as a whole was offset by 
the greater levels of SERCA2a in TAC vs. SHAM hearts in the SP and RV (12%, p = 0. 765; 
38%, p = 0. 246, respectively) (Figure 2.4). Phospholamban (PLB) amounts were 
significantly lower in the base than apex in the RV (-26.5%, p = 0.011) (Figure 2.5). NCX 
only differed significantly across regions. The ANOVA does not provide region-by-region 
statistics, however, so we are left to speculate about which regions were statistically different 
from each other (Figure 2.6). Perhaps unexpectedly, all other proteins studied showed no 
significant differences, either across spatial regions or between groups (SHAM vs. TAC). 
Somewhat surprisingly, neither MLCK nor PMCA exhibited any differences, either 
between groups or regions. This could be due to the low signal observed in the bands of these 
proteins when quantified using western blot (Figure 2.2). 
 
Figure 2.5. Regional distribution of PLB. Mean values were significantly lower in the 
base than apex of the RV (-26.5%, p = 0.011).  
(White = SHAM, Red = TAC) 
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2.3.3. Immunofluorescence Microscopy of Entire Ventricle Cross-Sections 
Figures 2.7 and 2.8 show the regional distributions of Cx43 and SERCA2a, 
respectively, in representative samples of normal rat LV myocardium. Although attempts 
were made to quantify regional distributions of Cx43 or SERCA2a density from these cross-
section fluorescent images, we struggled to identify a reliable and reproducible method. 
However, qualitatively, the density of Cx43 did appear slightly higher in EPI regions 
compared to MID and ENDO. In the case of SERCA2a, the EPI region is very bright, the 
ENDO region is less so, and the MID region is darkest. This result corresponds well with 
what we observed using western blot (Figure 2.4), though further studies will be required to  
 
Figure 2.6. Regional distribution of NCX. Mean values were markedly lower in TAC 
hearts vs. SHAM in the LV and SP regions, but not RV. There was a significant difference 
between regions, which is indicative of the higher values in the LV and SP than RV.  
(White = SHAM, Red = TAC) 
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Figure 2.7. Representative cross-sectional image of Cx43 immunofluorescent staining. 
Cx43 (green) and DAPI (blue) Autofluorescence is observed since there was no fluorescent 
label in the red color range. Cx43 appear as localized bands at the intercalated discs. Our 
imaging protocol allows for scanning entire cross-sections in the 10s of mms at high 
enough resolution to count nuclei or other cellular features. 
 
 
Figure 2.8. Representative cross-sectional image of SERCA2a immunofluorescent 
staining. SERCA2a (green) DAPI (blue) SERCA2a appears as a diffuse green color but 
was stronger than autofluorescence in tissues with no green label. The transmural pattern 
here reflects that observed with western blot. 
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determine whether the quantitative distribution of these and other proteins differs significantly 
between regions. 
2.4. Discussion 
In this work, we have used western blot and fluorescence microscopy of entire 
ventricle cross-sections to investigate the regional (especially transmural) distribution of 
protein densities in the rat ventricles after 4 weeks of pressure overload (TAC) and in SHAM 
controls. We observed several transmural or other regional gradients in these protein 
densities, as well as differences between TAC and SHAM groups, however, only a few of 
these achieved statistical significance. 
There were mostly favorable comparisons between our data and those reported 
previously, however there were also some discrepancies that should be addressed. Firstly, the 
transmural gradient we observed in Cx43 across the ventricle wall, with increasing levels of 
Cx43 from EPI to ENDO, is very consistent with what has been observed in the dog and 
mouse [12], [13]. However, Yamada, et al reported no transmural gradient of Cx43 in the rat 
[12]. However, they used Wistar rats whereas we used Sprague-Dawley, and this may explain 
the discrepancy. 
Our finding that SERCA2a decreases with POH comports with previous studies which 
showed similar decreases in SERCA2a expression [19]–[21]. The differential response in the 
right ventricle and septum vs the left ventricle has not to our knowledge been previously 
reported. Additionally, we are unaware of any report of regional variations in the density 
distributions of the remaining proteins we investigated herein.  
The functional implications of the regional gradients we observed in this study and the 
spatially heterogeneous remodeling of those structures are quite complex and a simple 
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explanation would be insufficient. We propose that the above data could be implemented into 
mathematical models of ventricular mechanics, as has been done previously [22]. Such 
models would help to elucidate the normal contributions of transmural gradients, and the 
functional ramifications of regional remodeling in a heart with POH. 
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3. Regional Variations in Diffusion Tensor Anisotropy are Associated with Myocyte 
Remodeling in Left Ventricular Pressure Overload 
3.1. Introduction 
Nearly one half of adults in the United States has hypertension [1]. The well-known 
response in the left ventricle (LV) to such pressure overload is concentric hypertrophy, which 
is characterized by the addition of sarcomeres in parallel within cardiac myocytes, resulting in 
ventricle wall thickening without chamber dilation. Such remodeling in pressure overload 
hypertrophy (POH) is considered a compensatory mechanism to maintain cardiac output 
despite increased downstream resistance to blood flow. This compensatory state, however, 
results in impaired diastolic filling, and often progresses to wall thinning, chamber dilation, 
impaired systolic function, and heart failure [2]–[4]. 
Many studies have described effects of pressure overload on structural features, e.g. 
myocyte hypertrophy, laminar sheet architecture, proteins (both myocyte and ECM), 
signaling, and gene expression networks [4]–[10]. However, it is unclear whether remodeling 
of these structural features during POH occurs uniformly in all regions of the LV. Several 
structural features in the normal LV have been shown to vary spatially, especially 
transmurally, in normal hearts [11]. These transmural gradients, together with other factors, 
are thought to contribute to normalizing the otherwise large gradients in “fiber” (parallel to 
myocytes) stress and strain during both diastolic filling and systolic contraction [11]–[16].  
For example, Campbell, et al observed a transmural gradient in myocyte geometry in 
isolated cells from normal hearts, with larger myocyte volume and cross-sectional area (CSA) 
in the sub-endocardium (ENDO) than midwall (MID) or sub-epicardium (EPI) [17]. In POH, 
this transmural gradient was “abolished” [18]. Conversely, Omens, et al showed that in intact, 
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fixed tissue, a transmural gradient in myocyte CSA only appeared after 3 weeks of aortic 
constriction, with increasing myocyte CSA towards ENDO [19]. Finally, McCrossan, et al 
reported a transmural gradient in myocyte geometry similar to that of Campbell, et al in 
normal hearts, but in POH, the gradient increased slightly, as opposed to being “abolished” 
[20]. These conflicting results could be due to differences in loading conditions, different 
strains of rat, experimental processes such as fixation, or other factors. Regardless, further 
study is required to elucidate the transmural variation in myocyte geometry in normal hearts 
and in those with POH. 
We [11] and others [16], [21] have summarized how transmural gradients in LV 
structures likely contribute to uniform fiber strain during diastole and systole, resulting in 
optimized ventricular function. Thus, it has been argued that uniform fiber strain is an 
important homeostatic principle in maintaining cardiac function, and therefore as myocardium 
grows and remodels due to chronic overloads, it will attempt to keep regional heterogeneity in 
fiber strain to a minimum. It has been shown that ventricular torsion, driven by the transmural 
variation in fiber angle, is a requirement for uniformity of fiber stress and strain (review by 
Russel, et al [22]). However, it is unclear whether this uniformity is actually preserved in 
POH due to the quantity of structural features that remodel, and the complexity with which 
individual structural components contribute to mechanics. It has also been shown that torsion, 
which is driven mainly by epicardial myocytes, is increased in POH [23]–[25]. Additionally, a 
distinct relationship between torsion and ventricle geometry has been shown wherein torsion 
increases with a decrease in the ratio of cavity area to wall area [26]. In this study, the 
observed increase in torsion during endocardial ischemia was explained by a decrease in 
endocardial shortening strain, exaggerating the contribution of orthogonally-oriented 
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epicardial regions [27]. Conversely, in pressure overload, it may be that epicardial shortening 
strain must increase to maintain optimal torsion and cardiac output despite the increased load. 
Therefore, we hypothesized that the structural remodeling response to pressure overload 
varies transmurally, including greater myocyte hypertrophy in EPI than in ENDO. 
Measuring variations in these structural features is not trivial and usually involves 
tissue sectioning, staining, imaging, and careful measurement. Not only is this time-
consuming and tedious, but such experiments cannot be performed in vivo, are destructive, 
and are usually only performed in small sub-regions of an organ or tissue. Non-destructive 
imaging is a much more appealing approach, especially methods which can relatively quickly 
and accurately capture the information in the entire organ or tissue of interest, while 
preserving 3D geometry. Diffusion tensor MRI (DT-MRI or DTI) has surfaced as one such 
technique to measure local structural orientations from eigenvectors, such as the local 
myocyte orientation described by the “helix” or “fiber” angle, and the laminar “sheet(let)” 
orientation described by the sheet angle [28]–[30]. The diffusion tensor not only provides 
orientation information in its eigenvectors, but also the apparent diffusivities along those 
eigenvectors in the eigenvalues. Some recent studies have described transmural variations in 
fractional anisotropy (FA), which is derived from the eigenvalues and indicates the degree of 
self-diffusion anisotropy [31]–[33]. Others have shown an increase in cross-fiber diffusivities 
and sheet reorientation in heart failure patients [34], [35]. These results are also somewhat 
conflicting and unclear, and even less well understood are the contributions of different 
structural features to variations in 3D diffusivity. Thus, a secondary objective of this study 
was to determine whether regional and pathophysiological variations in these structural 
features could be detected consistently using DT-MRI. 
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To test our hypothesis, we performed high-resolution, high-fidelity DT-MRI on 
transverse aortic constricted (TAC) and sham control (SHAM) rat hearts ex vivo, and 
investigated the regional variations in DTI-derived parameters of orientation, diffusivity, and 
anisotropy in the LV. In the same hearts, we performed quantitative measurements of 
myocyte orientations and dimensions from bright field and confocal microscope images, 
respectively, to corroborate our findings from DT-MRI and suggest potential structural 
contributors to regional variation in the DT-MRI signal. We found that there are indeed 
regional variations in myocyte geometry and structural organization which become more 
uniform in POH. Additionally, several structural features correlated significantly with DTI-
derived parameters, regardless of phenotype. This remodeling and the association with DTI 
are quite complex. Nonetheless, these results will be valuable in understanding the 
mechanisms by which cardiac myocytes in different regions of the LV respond to 
hypertension and may provide a tool for diagnosing the early stages of hypertrophy or other 
remodeling clinically and non-invasively, allowing for earlier lifestyle changes or 
interventions to reverse early stage remodeling before the progression to heart failure occurs. 
3.2. Methods 
3.2.1. Pressure Overload Hypertrophy Model and Tissue Preparation 
All animal studies were approved by the Institutional Animal Care and Use 
Committee at UCSD and followed the Guide for the Care and Use of Laboratory Animals. 16 
male rats weighing approximately 200 grams were randomly divided equally into TAC and 
SHAM groups. Rats were intubated and anesthetized with 1.25-2.00% isoflurane in air. An 
appropriate level of anesthesia was confirmed by toe pinch. Once sufficiently anesthetized, a 
small incision was made to expose the ascending aorta. In TAC animals, a hemo-clip was 
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inserted between the right innominate and left carotid arteries, then constricted to a width of 
0.5 mm. SHAM controls underwent the same procedure but did not have the clip inserted. 
The incision layers were closed and sutured, and the animal was allowed to recover fully. 
M-mode echocardiography was performed 1 day before surgery, and at 2 weeks and 4 
weeks after surgery. At 4 weeks, manometer (Millar, Houston, TX, USA) catheter recordings 
of aortic (proximal to the clip) and LV cavity pressures as well as concurrent 
electrocardiogram were also recorded. Hearts were then excised, weighed, and retrograde 
perfused with Krebs-Henseleit buffer until the tissue was cleared of blood and regular beating 
resumed. Cardiac arrest was achieved using a modified Krebs-Henseleit buffer with high 
potassium, and hearts were then fixed using Karnovsky’s fixative with 2mM gadolinium 
chelate (ProHance; Bracco, Eden Prairie, Minnesota, USA). For imaging, hearts were 
embedded in a 1% agarose gel containing 2mM gadolinium chelate. A subset of these hearts 
was used in a previously published imaging study [36]. 
3.2.2. Diffusion Tensor MRI Acquisition 
Images were acquired in a similar fashion to previously published data, with some 
modification [37]. Briefly, a 9.4 Tesla MRI magnet (Agilent, CA, USA) capable of a 
maximum gradient strength of 1 T/m was used, together with a 20 mm inner diameter 
birdcage coil (Rapid Biomedical, Rimpar, Germany). Important imaging parameters were as 
follows: TR = 250 ms, TE = 9.3 ms, echo spacing = 4.9 ms, echo train length = 8, FOV = 
21.6×14.4×14.4 mm, resolution = 100×100×100 μm, number of non-DW (b=0) images = 4, 
number of DW directions = 30 forward + 30 reverse, beffective = 1,000 s/mm
2, diffusion 
duration (δ) = 2 ms, diffusion time (Δ) = 5.5 ms. Total acquisition time per heart was 11.5 h. 
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3.2.3. Tissue Sectioning, Staining, and Confocal Microscopy 
After DT-MRI, whole heart samples were dissected into three sections after removal 
of the atria and valve plane: the right ventricle, interventricular septum, and LV free wall. 
Samples from the equatorial LV free wall were dehydrated in graded ethanol and embedded 
in paraffin wax for sectioning. Serial sections at 50 μm thickness were obtained parallel to the 
EPI through the entire ventricular wall using a microtome and mounted on slides. The staining 
protocol was similar to that described by Bensley, et al, but without the DAPI stain [38]. After 
 
Figure 3.1. DT-MRI of rat ventricles. (A) Non-diffusion weighted (b=0) image shows 
high SNR of the myocardium (33 ± 4 for all animals). (B) Example diffusion-weighted 
image. SNR for weighted images for all rats was 24 ± 4. (C) Diffusion tensors are rendered 
as glyphs whose color represents the orientation of the primary eigenvector (longitudinal 
tensors are red, circumferential are blue). 
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wax removal and rehydration, tissue sections were stained with wheat germ agglutinin 
(WGA) conjugated to Alexa Fluor 633 (Life Technologies, Carlsbad, California, USA). A 
Zeiss LSM 880 with Airyscan FAST (Zeiss, Jena, Germany) was used to acquire image 
volumes in FAST mode. Image stacks were acquired with the following settings: Objective = 
20x Pln/Apo, NA = 0.8, resolution = 0.2×0.2×0.4 μm, typical image size = 1220×1220×(80-
130) voxels. 
Bright-field images were also obtained of the same sections at low magnification 
(10X) on an EVOS FL Auto Microscope (Life Technologies, Thermo Fisher Scientific, 
Waltham, MA) to measure fiber angles and dispersions. Fiber angles and dispersions were 
measured using the image gradient technique described by Karlon, et al [39] implemented in-
house in MATLAB (The MathWorks, Natick, MA). The fiber angle and dispersion for a 
given section were defined as the circular mean and circular standard deviation of detected 
edges. 
3.2.4. Image Processing, Registration, Mesh Generation, and Parameter Calculation 
Diffusion Tensor MRI Processing 
Diffusion tensors were calculated from diffusion weighted images in AFNI [40] by 
solving the standard monoexponential, Gaussian model: 
𝑆(𝑏)
𝑆(0)
= exp⁡(−𝑏𝐷𝑎) 
 
where 𝑏 is the b-value [s/mm2] indicating the combined magnitude and duration of the 
diffusion gradient, 𝑆(𝑏) is the diffusion-weighted image signal, 𝑆(0) is the non-weighted 
image (b=0), and 𝐷𝑎 is the apparent diffusion coefficient [mm
2/s]. 
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Masks were generated by semi-automatic segmentation of the LV from b=0 images in 
Seg3D (SCI Institute, University of Utah, Salt Lake City, Utah). Papillary muscles and 
trabeculae were excluded from the segmentation. Segmented masks were converted into mesh 
surfaces, which were then divided into endocardial and epicardial surfaces and smoothed in 
Blender. An affine transformation was applied to align each data set with a consistent 
“cardiac” reference frame. The same affine transformation was applied to the calculated 
diffusion tensors using the log-Euclidian transform to preserve tensor properties [41]. A 
prolate spheroidal mesh template with 40 elements was fitted via least-squares to the LV 
endocardial and epicardial surfaces. This mesh served as a consistent datum across all hearts 
by which to measure local fiber and sheet angles from the eigenvectors, and to simply and 
consistently subdivide the tensor data by anatomical region (circumferential, longitudinal, and 
transmural position) for direct regional comparisons across all hearts. An example mesh with 
rendered diffusion tensors in a single image slice are shown in Figure 3.1C. 
 The eigenvectors from DT-MRI have been shown to agree closely with the local fiber, 
sheet, and sheet-normal orientations, respectively, and the eigenvalues represent the apparent 
diffusion coefficients along those principal directions [28], [30], [42]. Fiber and sheet angles 
were calculated as previously described [43]. Briefly, the fiber (“helix”) angle was defined as 
the angle between the local circumferential direction and the projection of the primary 
eigenvector onto the circumferential-longitudinal plane. The sheet angle was defined as the 
angle between the local radial direction and the secondary eigenvector. The dispersions of 
these angles were defined as the circular standard deviation of the angles in each spatial 
region. The fiber, sheet, and sheet-normal diffusivities are the primary, secondary, and tertiary 
eigenvalues, (𝜆1, 𝜆2, 𝜆3) respectively. The mean diffusivity (MD) is the mean of the three 
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eigenvalues. Fractional (FA), linear (CL), planar (CP), and spherical (CS) anisotropies were 
calculated from the eigenvalues, and their mean (?̂?) as described previously [44], [45]:  
𝐹𝐴 = ⁡√
3
2
√
(𝜆1 − ?̂?)2 + (𝜆2 − ?̂?)2 + (𝜆3 − ?̂?)2
(𝜆1
2 + 𝜆2
2 + 𝜆3
2)
⁡⁡ 
 
𝐶𝐿⁡ =
𝜆1 − 𝜆2
3?̂?
 
 
𝐶𝑃⁡ =
2(𝜆2 − 𝜆3)
3?̂?
 
 
𝐶𝑆 =
𝜆3
3?̂?
 
 
Confocal Micrograph Processing and Myocyte Geometry 
Confocal images were processed using Zeiss Airyscan Processing. Measurements 
were made of myocyte length, in-plane (parallel to the epicardial surface) myocyte width, and 
through-plane myocyte height. Lengths were defined as the longest dimension of the 
myocyte. Width and height were measured across visible nuclei, or across the largest cross-
section if no nucleus was visible. Aspect ratios were also computed for length:width ratio 
(L:W), length:height (L:H), and width-height (W:H). CSA was computed assuming an 
elliptical cross-section, with major and minor radii defined as half the width and height, 
respectively. Additionally, myocyte fractional anisotropy (MFA), analogous to FA from DTI, 
was calculated as: 
𝑀𝐹𝐴 =⁡√
3
2
√
(𝑙 − ?̂?)2 + (𝑤 − ?̂?)2 + (ℎ − ?̂?)2
(𝑙2 +𝑤2 + ℎ2)
⁡ 
 
where ?̂? is the mean of myocyte length (𝑙), width (𝑤), and height (ℎ).  
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3.2.5. Statistics 
All descriptive statistics in this work comparing SHAM and TAC groups are reported 
as mean ± SEM. For all statistical inference tests, p-values < 0.05 were considered statistically 
significant. Student’s unpaired, two-tailed t-test with assumed unequal variances was used to 
test for significance in differences between TAC and SHAM hypertrophic signals, such as 
heart weight to body weight ratio (HW/BW) and ejection fraction (EF).  
The DT-MRI data from each LV were divided into 600 anatomically registered 
regions (20 transmurally, 10 circumferentially, and 3 longitudinally). A multi-factor ANOVA 
 
Figure 3.2. Transmural gradients of DTI-derived parameters in the LV free wall. Data 
shown are mean ± SEM (n=16 SHAM, 16 TAC). Of note are the apparent increase in fiber 
angle across the wall in this region in TAC vs. SHAM, The transmural patterns of FA and 
slight decrease in FA in the ENDO, the differential patterns of CP between TAC and 
SHAM, and the corresponding differences in sheet dispersion. 
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for all variables was conducted, with surgical intervention, transmural, circumferential, and 
longitudinal positions as the four factors. Only between-group differences and the direct linear 
interactions between factors were considered. Correction for multiple comparisons was 
performed using the Tukey-Kramer method. For visualization, DT data were divided into 
5400 regions (20 transmurally, 30 circumferentially, 9 longitudinally). Group means and the 
normalized difference between groups (analogous to a t-score) was calculated for each of the 
5400 regions. Maps of these values are shown in Figure 3.3 and in the supplement. 
For correlations between parameters measured from DT-MRI and measurements from 
microscope images, Pearson’s correlation coefficient was calculated, along with the p-value 
for the linear correlation. A random permutation test with 10,000 permutations was performed 
to correct for multiple comparisons. Once significant correlations were found, analysis of 
covariance was applied to determine the relative contributions to correlation from the SHAM 
and TAC groups. 
3.3. Results 
3.3.1. Transverse Aortic Constriction and Left Ventricular Hypertrophy 
At four weeks post-surgery, the systolic pressures in the ascending aorta were 
significantly elevated in the TAC group compared to SHAM controls (186 ± 33 mmHg TAC 
vs 118 ± 9 mmHg SHAM, p<0.01). Animals in the TAC group were found to be in a state of 
compensated hypertrophy, with significantly higher heart weight to body weight ratio (4.91 ± 
0.45 g/kg TAC vs 3.42 ± 0.16 g/kg SHAM, p<0.001), and a significantly lower, yet still 
normal, (i.e. >50%) EF (79±1% SHAM vs. 72±2% TAC, p<0.01). Table 3.1 summarizes the 
key differences found between SHAM and TAC hearts.  
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Table 3.1. Summary of echocardiographic data 
 
Cardiac phase Variable Units SHAM (N=8) TAC (N=8) p-value 
End-diastole 
IVS [mm] 1.15±0.02 1.47±0.03 <0.001 
LVID [mm] 7.80±0.19 8.13±0.22 0.30 
LVPW [mm] 1.50±0.07 2.00±0.12 <0.01 
PAo [mmHg] 85±2 77±4 0.11 
End-systole 
IVS [mm] 1.51±0.10 1.80±0.11 0.10 
LVID [mm] 4.45±0.15 5.09±0.21 <0.05 
LVPW [mm] 2.53±0.10 2.94±0.12 <0.05 
PAo [mmHg] 118±3 186±11 <0.001 
-- 
FS [%] 43±1 37±1 <0.01 
EF [%] 79±1 72±2 <0.01 
CO [L/min] 0.29±0.02 0.28±0.02 0.92 
BW [g] 334±8 324±6 0.36 
HW [g] 1.14±0.02 1.59±0.04 <0.001 
HW/BW [g/kg] 3.42±0.05 4.91±0.15 <0.001 
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Figure 3.3. Regional variations in select DTI-derived parameters. The comparison 
between fiber angles in SHAM (top row) and TAC (middle row) animals is indicated by the 
t-score (bottom row). The data from the LV equatorial lateral wall (in the right-hand side of 
the circles in the middle column) are also represented in Figure 3.2. Figure 3.3 continues 
on the following page. 
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Figure 3.3. (Continued) Regional variations in sheet dispersion. Figure 3.3 continues on 
the following page. 
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Figure 3.3. (Continued). Regional variations in fractional anisotropy (FA). Figure 3.3 
continues on the following page. 
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Figure 3.3. (Continued) Regional variations in planar anisotropy (CP). 
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3.3.2. Diffusion Tensor MRI 
The mean (± standard deviation) signal to noise ratio (SNR) of the b=0 images across 
all hearts was 33±4, where the SNR for each heart was defined as 
𝑆𝑁𝑅 =
𝐼?̅?𝑖𝑔
𝜎𝑏𝑘𝑔
 
 
where 𝐼?̅?𝑖𝑔 is the mean intensity of voxels in a region of myocardium, and 𝜎𝑏𝑘𝑔 is the standard 
deviation of voxel intensities in a region of background signal. In diffusion weighted images, 
the mean SNR across all animals was 24 ± 4. Representative b=0 and diffusion weighted 
images are displayed in Figure 3.1A-B. Figure 3.2 shows the transmural distributions of the 
twelve major variables discussed in this work in the equatorial LV lateral wall. Notably, the 
fiber angles in this region were consistently slightly higher in TAC animals compared to 
SHAM controls by approximately 7-8 degrees at all points across the wall. In the opposite 
(septal) wall, fiber angles were practically identical across the wall, except in the epicardial 
region, where fiber angles were slightly lower in TAC animals compared to SHAM controls 
(Figure 3.3). Also of interest is the transmural variation in planar anisotropy (CP) and sheet 
dispersion. 
The regional analysis of diffusion tensor-derived parameters produced several other 
interesting results, which are summarized in Table 3.2. Regional variations in some key 
variables of SHAM and TAC hearts, as well as the normalized difference between the groups, 
are shown in Figures 3.3. The main differences found between SHAM and TAC groups were 
as follows: The fiber angle was significantly different in both the mean and the interactions 
transmurally, circumferentially, and longitudinally, and was apparently slightly higher in the 
posterolateral EPI (i.e. more circumferential), and slightly lower in the anterior  
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Table 3.2. ANOVAs for DT-MRI parameter regional variation 
 
Variable Hypertrophy Hyp*Trans Hyp*Circ Hyp*Long 
Fiber Angle <0.001 <0.001 <0.001 <0.01 
Fiber Dispersion <0.001 <0.001 <0.01 <0.001 
Sheet Angle <0.01 0.19 <0.001 <0.001 
Sheet Dispersion <0.001 <0.01 <0.05 <0.001 
Fiber Diffusivity (𝜆1) 0.559 -- -- -- 
Sheet Diffusivity (𝜆2) 0.449 -- -- -- 
Sheet-Normal Diffusivity (𝜆3) <0.05 <0.05 0.568 0.994 
MD (?̂?) 0.187 -- -- -- 
FA <0.01 <0.001 0.697 <0.001 
CL 0.388 -- -- -- 
CP <0.001 <0.001 0.89 0.24 
CS <0.001 <0.001 0.75 <0.001 
 
 
Table 3.3. ANCOVAs for correlations between DT-MRI and histological measurement 
 
DTI Parameter 
Histo 
Parameter 
Best 
ANCOVA 
R2 
Correlation 
p-value 
ANCOVA  
p-value(s) 
Fiber Angle 
Fiber Angle Same Line 0.71 <<0.001 (6e-9) 
L:W Same Line 0.23 0.0073 
Fiber Dispersion 
Fiber Angle Parallel Lines 0.23 0.0078 0.0063/0.0008 
Myocyte Width Same Line 0.31 0.0013 
L:W Separate Lines 0.30 0.0019 0.0363/0.0046 
Sheet Dispersion 
Fiber Angle Same Line 0.20 0.0130 
L:H Same Line 0.25 0.0049 
Fiber Diffusivity  Fiber Angle Separate Lines 0.27 0.0036 0.0121/0.0025 
Sheet Diffusivity  W:H Same Line 0.21 0.0112 
MD W:H Same Line 0.25 0.0053 
FA Fiber Angle Same Line 0.48 <0.001 (2e-5) 
CL Fiber Angle Same Line 0.56 <0.001 (2e-6) 
CP 
Fiber Angle Same Line 0.27 0.0032 
L:W Same Line 0.24 0.0062 
MFA Same Line 0.24 0.0057 
CS Fiber Angle Same Line 0.26 0.0038 
 
ENDO (also more circumferential) in TAC vs SHAM. The sheet dispersion was lower on 
average in TAC hearts compared to SHAM, and the interactions with transmural, 
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circumferential, and longitudinal position were also significant. Although the diffusivities 
alone did not show much collective significance in the ANOVA, there was an apparent 
transmural-longitudinal shift in all three, with lower diffusivities in ENDO and apical regions 
in TAC vs SHAM. There was a notable transmural gradient of FA in both SHAM and TAC 
hearts, and this value appeared to decrease in the ENDO and apical regions, whereas it was 
increased elsewhere in TAC hearts.  
 
Figure 3.4. Orthogonal views of a representative confocal image volume. The 
extracellular space is clearly visible with the WGA stain (red), including t-tubule patterns. 
Cell ends are also visible, making measurement of myocyte length possible, as shown for 
example by the white arrow. Out-of-plane dimension can also easily be measured in 
orthogonal views. Scale bar: 50 micrometers. 
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3.3.3. Confocal Micrographs 
A representative image volume is shown in three orthogonal views in Figure 3.4. The SNR in 
the central slice of these image volumes was approximately 50. Lateral and longitudinal cell 
borders are clearly distinguishable, and t-tubules are also visible. Transmural plots of myocyte 
length, width, and height, as well as CSA and MFA are shown in Figure 3.5. As expected, 
myocytes in TAC hearts exhibited a larger width and height compared to SHAM controls. 
SHAM hearts showed a transmural gradient in myocyte CSA, increasing from EPI to ENDO. 
The transmural gradient in CSA was diminished in TAC hearts, with increasing CSA across 
the wall, similar to previously measured data [18]. 
3.3.4. Correlations Between DT-MRI and Myocyte Geometry 
Several correlations were found to be statistically significant between the DT-MRI 
data and measurements of myocyte geometry. As expected, fiber angles measured from bright 
field images and from DTI correlated significantly (p<0.001, R2=0.71). Fiber angles from DTI 
also correlated with L:W ratio (p<0.01, R2=0.23), indicating that MFA varies transmurally. 
Additional significant correlations between DTI-derived parameters and those measured from 
confocal images of tissue sections were as follows: Fiber diffusivity (𝜆1) and all anisotropy 
metrics correlated significantly with fiber angle (p<0.01, R2=0.27), again, indicating a 
transmural gradient. Planar anisotropy correlated significantly with fiber angle (p<0.01, 
R2=0.25), myocyte width (p=0.025, R2=0.16), MFA (p<0.001, R2=0.33), and CSA (p=0.019, 
R2=0.17). Sheet-normal diffusivity (𝜆3) correlated significantly with MFA (p=0.015, 
R2=0.18). The results of ANCOVA tests are presented in Table 3.3. Six of these correlations 
are also plotted in Figure 3.6.  
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Figure 3.5. Summary of measurements from histological sections. (A) Transmural plots 
of fiber angle measurements from bright field images. (B) As expected, fiber angles 
correlated significantly (p<0.0001) with those from DTI. (C) Myocyte CSA exhibited a 
transmural gradient in SHAM hearts, with larger values in the ENDO. In TAC hearts, CSA 
was elevated, and the transmural gradient was diminished. (D) A Transmural gradient in 
myocyte fractional anisotropy (MFA) was observed, with lower values in the ENDO, 
especially in SHAM myocytes. 
 
 
3.4. Discussion 
In this work, we have shown that transmural gradients in myocyte geometry are 
present in the normal rat LV but are reduced in POH. This normal transmural gradient is 
characterized by larger myocyte CSA in ENDO than EPI. This is especially obvious in the 
transmural pattern of CSA and MFA (Figure 3.5C-D). The observed reduction in this 
gradient in POH is similar to the results of Campbell, et al [18]. We also observed a difference 
in the transmural patterns of several other structural features, as measured from DT-MRI. One 
of importance is that of the orientation and dispersion of sheet structures. In agreement with 
our hypothesis, we observed that the transmural gradients in both the mean sheet angle and  
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the dispersion of those angles about the mean, were more transmurally uniform in the LV of 
rats with POH. This does not indicate that sheet angles are globally reoriented to become, for 
example, more radially aligned as others have observed [35]. Rather, transmural variation is 
reduced so that across the wall, the orientation and dispersion of sheet structures were similar. 
Also of note, CP varied in the equatorial LV free wall, with a different pattern in SHAM than 
TAC hearts. In this region, CP decreased from EPI to ENDO in SHAM hearts, with a low 
 
Figure 3.6. Correlations between DTI and histology. Grayscale color of markers 
indicates transmural location (black: ENDO, white: EPI). (A-B) Both linear and fractional 
anisotropy, respectively, exhibited a strong correlation with fiber angle, indicating that 
these parameters vary transmurally. (C) Sheet dispersion correlated with L:H ratio, (D) 
Mean diffusivity correlated with W:H ratio, and (E-F) Planar anisotropy correlated 
negatively with both L:W and MFA. 
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point in MID, whereas in TAC hearts, CP was lower in EPI and ENDO regions, with a high 
point in MID (Figure 3.2).  
Others have reported transmural gradients and responses to POH in the rat LV with 
different patterns than the present study [19], [20]. There are many factors that could 
contribute to these differences, including rat strain, the method of inducing pressure overload, 
and differences in measurement methods. However, our results do agree nicely with those of 
Campbell, et al, who showed a transmural gradient in myocyte CSA which is normalized in 
POH in the rat [17], [18]. Others have reported that transmural gradients in mitochondrial 
respiratory chain activity and oxidative stress are normalized in POH [46]. As sarcomeres are 
added and myocyte volume increases, the metabolic capacity must also increase to facilitate 
the energetic demands of those additional sarcomeres. It is clear that a remodeling balance 
must be achieved between the need to respond to the increase in downstream resistance to 
blood flow and the mechanical optimization of maintaining uniform fiber stress and strain 
under such conditions. Other structural features which exhibit a transmural gradient in normal 
tissue remodel during POH, such as titin isoform ratio, which modulates stiffness in pacing 
tachycardia, a model of heart failure [47], [48]. The remodeling of titin isoform leads to a 
relative increase in passive stiffness which, along with fibrosis and collagen remodeling, 
likely contribute to diastolic dysfunction. 
Previous studies have shown transmural gradients in FA in normal hearts of sheep, 
human (in-vivo), and rat [31]–[33]. In sheep hearts, FA was lower in ENDO compared to 
MID or EPI regions [31]. In the human study, FA was higher in MID than ENDO or EPI [32]. 
Finally, in normal rat LV, a gradient of increasing FA from EPI to ENDO was observed [33]. 
In the current study, we observed an opposite trend to that of Giannakidis, et al, but similar to 
 91 
that in sheep hearts, namely, with generally increasing values of FA from ENDO to EPI. 
Although Giannakidis, et al state that their result is consistent with measurements of myocyte 
CSA by McCrossan, et al [20], it is unclear how a decrease in L:W ratio would result in an 
increase in FA. Conversely, our results indicate a more logical correspondence between a 
decrease in FA when the L:W ratio decreases. In other words, the cell membranes of rounder 
myocytes with a lower aspect ratio would restrict diffusion in a more isotropic manner than 
longer, thinner (more anisotropic) myocytes. The same argument holds when comparing our 
results to those described by Campbell, et al, who showed that in normal Sprague-Dawley 
rats, myocytes in the ENDO had larger CSA than EPI [17]. However, we did not observe a 
significant reduction of the gradient of FA in TAC, as one might expect from the results of a 
follow-up study by Campbell, et al [18]. 
To our knowledge, this is the first study to show correlations between DTI-derived 
parameters and myocyte geometry measurements in the same hearts. Others have used a 
similar approach to validate that the eigenvectors correspond with local fiber and sheet 
orientations [28], [42], [49], and more recently, that the eigenvalues correlate with collagen 
content [34]. The correlations we observed between variables from DTI and measurements 
from histology were statistically significant, which may indicate that the DTI variables are 
influenced by myocyte geometry. Additionally, however, several of those same variables 
derived from DTI correlated significantly with the measured fiber angle, which features a 
roughly linear transmural gradient. This may indicate that both myocyte geometry and some 
other structural features which contribute to variation in DTI-derived parameters also vary 
transmurally, giving rise to the moderate correlations we observed. In reality, the restriction to 
self-diffusion of water at the 100-micrometer scale is highly complex [50] so it is likely that 
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structural features other than myocyte geometry (such as collagen content and composition) 
influence the diffusion weighted signal. However, we postulate that myocyte geometry plays 
an important role at the 100-micrometer resolution of our DTI scans. Potential methods to 
understand the contributions of different structural features to variation in DTI include 
simulation [51]–[53], and dPFG or mPFG pulse sequences or qMAS diffusion encoding [54]. 
Several limitations to this study are worth consideration. First, eight rats in each group 
is a relatively small number, and a better understanding of the differences between TAC and 
SHAM animals would require more. However, even with a relatively small N we were able to 
observe statistically significant, regionally varying differences in many DTI-derived 
parameters, as well as significant correlations with measurements from histological sections. 
Second, the region for correlating between DTI and histological measurement was limited to 
the LV free wall. This region was chosen because it is the most commonly studied. The nature 
of sectioning, staining, and imaging limits the expanse of regions that can be analyzed using 
this method. An interesting follow-up study would be to predict with a statistical degree of 
certainty myocyte geometry based on DTI in a different region, such as the septum. Third, 
due to the direction of sectioning for confocal imaging, we could not validate sheet angle 
measurements. However, this has previously been done and close agreement was found 
between DTI-derived sheet angles and those from histological measurement [30], [42]. Lastly, 
all image data acquisition was performed on fixed hearts. The process of fixation alters the 
microstructural environment by cross-linking proteins, and tissue shrinkage is a known side-
effect. Thus, 3D diffusivity may not be completely representative of that in vivo. 
Additionally, further shrinkage is known to occur during processing of samples for histology. 
Despite these structural changes in tissue structure, we observed significant correlations in 
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multiple variables, indicating that the essence of tissue anisotropy and microstructure was 
preserved during fixation and histological processing. 
We conclude that regional variations in tissue microstructural features are evident in 
normal hearts, and that remodeling during POH is spatially non-uniform, with apparently 
more myocyte remodeling in MID and ENDO regions than EPI. We have also shown that 
regional remodeling can readily be detected using cardiac DTI, with indications that 
parameters such as sheet dispersion and measures of anisotropy correlate significantly with 
variations in myocyte geometry, such as L:W ratio and MFA. As DTI is refined for in-vivo 
use in humans, this method appears to provide a non-invasive, comprehensive method to 
detect cardiac tissue microstructure and its remodeling during disease. 
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3.6. Appendix: Additional Figures 
 
Figure 3.7. Regional distributions of additional DTI-derived parameters. Regional 
variations in fiber dispersion. Figure 3.7 continues on the following page. 
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Figure 3.7. (Continued). Regional variations in sheet angle. Figure 3.7 continues on the 
following page. 
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Figure 3.7. (Continued). Regional variations in fiber diffusivity (𝜆1). Figure 3.7 continues 
on the following page. 
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Figure 3.7. (Continued). Regional variations in sheet diffusivity (𝜆2). Figure 3.7 continues 
on the following page. 
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Figure 3.7. (Continued). Regional variations in sheet-normal diffusivity (𝜆3). Figure 3.7 
continues on the following page. 
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Figure 3.7. (Continued). Regional variations in mean diffusivity (?̂?). Figure 3.7 continues 
on the following page. 
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Figure 3.7. (Continued). Regional variations in linear anisotropy (CL). Figure 3.7 
continues on the following page. 
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Figure 3.7. (Continued). Regional variations in spherical anisotropy (CS). 
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4. Myocardial Infarction Sizing in the Mouse by 3D Multiplanar Reconstruction of 
Late Gadolinium Enhanced Magnetic Resonance Cardiac Imaging: Correlation 
with Regional Left Ventricular Dysfunction and Contractile Reserve 
4.1. Introduction 
Investigations of pharmacologic, cell-based, and gene treatments for the adverse 
effects of myocardial infarction (MI) are hampered by imprecise in vivo measurements of the 
extent of associated left ventricular (LV) regional dysfunction [1], [2]. Most contemporary 
small animal, cardiovascular experimental laboratories depend on two-dimensional (2D) 
echocardiography, with incorporated speckle tracking [3], for assessment of LV global and 
regional function. Despite its sophistication and easy implementation, 2D echocardiography 
remains limited perforce by planigraphic views that reflect incompletely the full, or three-
dimensional (3D), extent of left ventricular myocardial shortening. 
Some investigators have attempted to address shortcomings of 2D echocardiography 
by 3D reconstruction of 2D ultrasound images, acquired on a platform with micrometer 
precision rotation and translation and a holder device for probe stability [4], [5]. Relatively 
favorable intra-observer, inter-observer, and interstudy variability in calculations of LV 
volumes, mass, and ejection fraction (EF) were reported. We encountered technical difficulty 
in implementing such a protocol and have turned, along with others, to cardiac magnetic 
resonance imaging with late gadolinium enhancement (LGE) to evaluate myocardial infarct 
size and its associated pathophysiology and pathoanatomy [6]–[19]. 
When combined with cine-MR protocols, LGE MR images provide information on 
both cardiac structure and function, as well as an accurate non-invasive method to determine 
the MI size compared with histological standards. Gadolinium provides relatively selective 
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labeling of the area of injury in the near-term days following an infarct [13]. Membrane 
disruption of cardiomyocytes and increased capillary permeability within infarcted regions 
result in an expansion of extracellular volume, and this allows LGE to infiltrate, thus 
reflecting the area of myocardial damage after infarction. LGE MR-determined MI size has 
been widely used in human and mouse models with relatively good accuracy in predicting 
long-term mortality [19], as well as cardiac function and remodeling [8], [9], [11]. 
Nevertheless, in most of these studies, the degree of associated regional myocardial 
dysfunction has been quantified using a 2D analysis, with minimal use of parametric 3D 
display and without normalization of regional wall motion to overall ventricular size. 
We aimed in this murine experiment, using 3D constructs, to compare in vivo LGE-
MI and post-mortem histologic infarct size with both regional dysfunction and left ventricular 
contractile reserve, assessed early (2 days) and late (4 weeks) following the onset of injury. 
Endocardial segmentation of multiplanar (base to apex) slices, with subsequent 3D 
reconstruction, was utilized to define both global and regional LV function. The ultimate goal 
was to provide tissue and functional standards for measuring infarct size against which 
therapeutic interventions could be more accurately compared.  
4.2. Methods 
4.2.1. Animal Model and Experimental Protocol 
All procedures were conducted according to established guidelines, and with the 
approval of the UC San Diego Institutional Animal Care and Use Committee (IACUC). A 
total of 22 male, C57BL/6J mice were purchased from a licensed vendor (Jackson Laboratory, 
Bar Harbor, ME) and used in this study. Of these 22 mice, 3 died before the MRI scan on day 
2 post-MI, 5 died before the MRI scan on week 4, and 3 died before finishing the 
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hemodynamic study on week 4. For the remaining 11 mice, the baseline body weight was 
24.6 ± 1.5 g, mean age was 12.4 ± 0.3 weeks. 
4.2.2. MI Surgery 
The mouse model of chronic myocardial infarction was produced by ligation of the 
anterior descending branch of the left coronary artery (LAD) as previously described [Kumara 
2005]. Briefly, mice were anesthetized with 1-1.5% isoflurane, intubated via the trachea, and 
mechanically ventilated with room air (respiratory rate 55–65 breaths per minute, tidal 
volume 2.5 ml). Under sterile conditions, a left anterior thoracotomy was performed to expose 
the heart. The left anterior descending coronary artery was ligated between the right 
ventricular outflow tract and the left atrium with a 6-0 silk suture that was passed through the 
superficial layers of myocardium [20]. The lungs were then reinflated and the chest incision 
closed. 
4.2.3. MRI Protocol 
All mice were scanned on a horizontal Bruker Biospec 7T/20 MRI system (Bruker, 
Germany). MRI scans were performed 1-2 days before surgery as a baseline, then follow-up 
scans were done 2 days and 4 weeks after surgery. Animals were anesthetized with 2% 
isoflurane in oxygen [11]. Heart rate ranged from 350 to 450 bpm, and respiratory rate was 30 
to 40 breaths per minute. Two metallic needles were placed subcutaneously over the axillary 
area to monitor the ECG signal, and a pressure transducer was placed under the animal’s back 
to monitor respiration. The body temperature was monitored and maintained at 37°C by a 
feedback controlled forced air heating system (SA Instruments, Stony Brook, NY). The ECG 
and respiratory signals were sent to a gating system (SA Instruments) for simultaneous ECG 
triggering and respiration gating. 
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MR images were acquired with a quadrature birdcage transceiver coil. All imaging 
protocols were performed with the animal lying on its back, with no rotation of the spine. For 
LGE imaging, a 30μL bolus of 0.5 mmol/kg Gd-DTPA (Magnevist®, Schering Healthcare, 
UK) was given by intraperitoneal injection 20-50 minutes prior to the MR scan [21], Figure 
4.1B. A coronal view was used as a long axis reference. Short axis planes were manually set 
perpendicular to both the coronal plane and the long axis. In mice, 6-7 (depending on heart 
size) contiguous short axis slices were required to cover the entire left ventricle. FLASH-
CINE images were acquired with the following image acquisition parameters: FOV: 1.5 × 2.0 
cm, matrix size: 128 × 128, slice thickness: 1 mm, inter-slice distance: 1 mm, echo time: 2.1 
msec, repetition time: 6 msec, 6 averages, flip angle: 40°, and 20 frames per cardiac cycle. 
For a single slice, the total acquisition time was approximately 100 to 110 seconds. 
Acquisitions were synchronized with the peak of the QRS complex. On average, MRI 
sessions were 35 ± 5 minutes per mouse. 
4.2.4. Hemodynamic Measurements 
Hemodynamic measurements were acquired within 1-2 days after the 4 week MR 
scan. Before cardiac catheterization, the mice were anesthetized with an intraperitoneal 
injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). The animals were then intubated, 
placed on a ventilator (100-110 stroke/min, 0.4-0.5 mL stroke volume), and the right carotid 
artery exposed. The femoral vein was cannulated with stretched PE50 tubing for drug 
administration. A 1.4 French high fidelity catheter-tip micromanometer (Millar Instruments, 
Houston, TX) was inserted retrograde into the aorta via the left carotid artery and advanced 
into the left ventricle. 
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After bilateral vagotomy, baseline pressures were recorded when pressure returned to 
a stable state. Dobutamine was given through the femoral vein at successively higher dosages 
of 0.75, 2, 4, 6 and 8 μg/kg/min. Pressure data was analyzed three minutes after the 
administration of each dose. Pressure was recorded through the LabChart acquisition system 
(AD Instruments), and analyzed by a custom-made program (HeartBeat) as described 
previously [20].  
4.2.5. Post-Mortem Histology 
Immediately following the hemodynamic study, the mouse was treated with 200 μL 
heparin (1000 units/mL) and 0.3M PBS KCl solution was injected through the inferior vena 
cava for induction of diastolic cardiac arrest. After surgical isolation from the right ventricle 
and atria, the LV was weighed, frozen on dry ice, and kept at -20°C for 40 minutes. A tissue 
matrix and stainless steel blades (Electron Microscopy Sciences, Hatfield, PA) were then used 
to cut the LV into 6-8 transverse slices, the thickness of which was approximately 1 mm. 
These slices were transferred into a 1.5% 2,3,5-triphenyltetrazolium chloride (TTC) solution 
and incubated at 37°C for 15 minutes. The slices were then immersed in 10% neutral formalin 
for 1 hour to enhance the contrast between the viable myocardium and scar tissue. The TTC-
stained slices were finally scanned (4800 dpi) for the measurement of infarction size [22]. The 
MI size was calculated by an area-based algorithm (Figure 4.1C), and expressed as a 
percentage of LV mass, inasmuch as this algorithm had been reported to give the same 
relative relationship of MI size measured as that by a length-based algorithm [23]. 
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4.2.6. Image Analysis 
End-diastolic (ED) and end-systolic (ES) frames were chosen as those with the largest 
and smallest chamber area, respectively, and slices were stacked into a 3D image volume. 
Each slice was zero-filled to improve the smoothness of resulting endocardial and epicardial 
borders. Seg3D (Scientific Computing Institute, University of Utah, Salt Lake City, Utah) was 
used to manually create a mask of the myocardium, excluding papillary muscles and 
trabeculae when defining the endocardial surface (Figure 4.1A). An in-house developed 
script was written in MATLAB® (MathWorks, Natick, MA), to read in the myocardial 
masks, detect the endocardial and epicardial borders, and register those data into scanner 
space. Data were interpolated along the long axis using cubic interpolation to improve mesh 
fitting in Continuity 6 (National Biomedical Computation Resource), as described below. 
4.2.7. 3D Reconstruction in Continuity – 3D Kinesis Analysis 
The borders derived from MR images were imported into Continuity (6.4b revision 
8234, National Biomedical Computation Resource) for 3D reconstruction and regional  
 
Figure 4.1. Segmentation of MRI and TTC images. (A) The segmentation of endocardial 
(interior) and epicardial (exterior) borders in Seg3D (segmented in red). (B) Myocardial 
infarction tissue on an LGE MR image (segmented in red). (C) Corresponding post-mortem 
slice of left ventricle with TTC staining of area of infarction (segmented in red). 
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displacement analysis. In Continuity, a prolate spheroidal finite element mesh was fitted using 
least squares to the data points of ED borders to form the ED mesh. The ES border underwent 
the same fitting process to create the ES mesh. Initially, 50 nodes were arranged on each fitted 
mesh, and after the refining process, a total of 300 nodes were rendered according to the 
curvature of the mesh surface [12].  
Displacement between ED and ES was determined as the Euclidian distance 
(calculated based upon Cartesian coordinates x, y, and z in 3D space) between corresponding 
nodes on the ED and ES endocardial mesh surfaces. For rendering purposes in order to better 
understand endocardial 3D deformation, a composite mesh was created with outer and inner  
 
Figure 4.2. RSAC Algorithm. Illustration of the algorithm used to calculate the RSAC of 
each surface area element. Triangulation was used to calculate the two areas comprising 
each of the rectangular-like elements created by the fitted mesh for both end-systolic (ES, 
white numbering) and end-diastolic (ED, black numbering) surfaces. 
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surfaces representing the endocardial surface at ED and ES, respectively (Figure 4.3). For all 
other analyses, the 80 most apical nodes were excluded to avoid error since no reliable image 
data were available in these regions. The 3D Kinesis (3DK) was defined as the Euclidian 
distance a between a node’s position at ED and ES. 
4.2.8. MRI Determination of LV Mass and LV Ejection Fraction 
Both ED and ES chamber volumes (EDV and ESV, respectively), and ED myocardial 
volume (EDMV) were calculated from the fitted meshes in Continuity. LV EF was then  
derived. LV mass was calculated by ED myocardial volume multiplied by myocardial specific 
gravity, γmyo (1.055 g/cm3): 
 
Figure 4.3. Representative serial parametric images of infarcted mouse heart. Note the 
change in relative wall motion and cardiac remodeling post-myocardial infarction. Top row 
is an anterior view, bottom row is a posterior view. Color-coded parametric images, left to 
right, show raw (baseline) and calculated Z scores for 3D-kinesis (3DK) at baseline, 2 days 
post-MI, and 4 weeks post-MI. The % of abnormal 3DK values (-2.0 SD’s) were 14.6% and 
31.4%, respectively, at 2 days and 4 weeks. 
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𝑀𝑎𝑠𝑠𝐿𝑉 = 𝛾𝑚𝑦𝑜 × 𝐸𝐷𝑀𝑉 
These MRI-derived estimates of LV mass were compared with the LV wet weight of all 
surviving mice (n=11). 
4.2.9. 3D Reconstruction in Continuity – Regional Surface Area Change Analysis 
In order to evaluate the effects of the infarction on regional circumferential and 
longitudinal myocardial shortening, excluding radial movement, the SQUEEZ algorithm 
developed by Pourmorteza et al. in 2012 [24] was modified for the generated LV model to  
calculate 3D regional surface area change (RSAC). The 3D RSAC values were calculated on 
each surface element according to the following formula: 
𝑅𝑆𝐴𝐶 = ⁡√
𝐴𝑟𝑒𝑎𝐸𝑆
𝐴𝑟𝑒𝑎𝐸𝐷
⁄  
In order to fit a node-based data structure on the mesh, a RSAC value was assigned to each 
node by averaging the RSAC values of its surrounding elements, (Figure 4.2). 
4.2.10. Regional Variability of Contraction 
Since myocardial kinetic movement varies from region to region of the heart, applying 
a single threshold for abnormality to an absolute displacement parameter may reveal false, 
sub-threshold values in some regions of a normal heart. Therefore, a comparison based upon 
the geometric variability of normal left ventricular motion is necessary. Similar to the work of 
Sheehan et al in the so-called “centerline method” for 2D wall motion analysis [25], [26], we 
used control (pre-infarction) measurements to calculate the baseline mean and standard 
deviation for each individual node (1-220) for each wall motion parameter (3DK and RSAC).  
The statistical distribution of each control node was then applied to the linear 
transformation of every corresponding node post-MI to calculate a so-called Z score, 
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according to the formula below (Xi indicates the parameter on node i, where i = 1 to 220) 
[25], [26]: 
𝑋𝑖,𝑍 =
𝑋𝑖,𝑖𝑠𝑐ℎ𝑒𝑚𝑖𝑐 − 𝑋𝑖,𝑚𝑒𝑎𝑛⁡(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
𝑆𝐷𝑖,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
For 3DK, a node that moved less than 2.0 standard deviations from the mean of the 
control group was classified as akinetic/dyskinetic (abnormal). For RSAC, a node with its 
normalized value larger than 2.0 standard deviations was similarly classified as abnormal. For 
analysis of the post-MI evolution of individual nodes, those values beyond -2.0 (3DK) or +2.0 
(RSAC) standard deviations were classified as clearly “abnormal” and within the MI zone, 
and those with values between -1.5 to - 2.0 (3DK) or +1.5 to +2.0(RSAC) were classified as 
within the peri-MI zone. 
A pseudo-color spectrum, calibrated to the magnitude of a given shortening parameter, 
was used to create a 3D parametric display of endocardial movement in relation to 
topographic location, Figure 4.3. As expected, the baseline parametric image displayed 
relatively uniform color (homogeneous regional contraction) and the post-infarct color display 
reflected the heterogeneity of abnormal regional wall motion, Figure 4.3. The 3D 
reconstruction can be shown in any given projection. In Figure 4.3, the top row represents an 
anterior-posterior projection, whereas the bottom row is posterior-anterior. Dynamic display 
of the transition between ED and ES showed clearly an area of abnormal kinesis in relation to 
its topographic location. The mesh composite provides a reference frame to see the change in 
endocardial surface shape from ED (outer wireframe surface) to ES (parametric image). For 
both normalized parameters (3DK, RSAC) the amount of abnormal myocardium (hence the 
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“functional infarct size”) was calculated by summing the number of all abnormal nodes, and 
was expressed as a percentage of the total of 220 nodes. 
4.2.11. MRI Determination of Myocardial Infarction Size 
ED LGE images of each slice were selected for infarction scar delineation. The 
infarction scar borders were traced by an observer in ImageJ (NIH,  using a semi-automatic 
segmentation plugin (JFilament) to minimize observer influence on the ROI [27].  In order to 
exclude artifacts, adjacent frames at the same slice location and adjacent slices were also used 
as references. The observer was blinded from hemodynamic information during image 
segmentation. The sizes of the contrast-enhanced areas in the MR images were plotted against  
the corresponding areas obtained from TTC staining, as shown in Figure 4.4B. Infarction size 
was expressed as a percentage of LV mass: 
𝐿𝐺𝐸⁡𝑀𝐼⁡𝑠𝑖𝑧𝑒 = 100% × [𝛾𝑚𝑦𝑜∑ (𝐸𝐷⁡𝑎𝑟𝑒𝑎𝑠𝑐𝑎𝑟) × 𝑠𝑙𝑖𝑐𝑒⁡𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠
𝐴𝑝𝑒𝑥
𝐵𝑎𝑠𝑒
] /⁡𝐿𝑉⁡𝑚𝑎𝑠𝑠 
 
 
Figure 4.4. Verification of MRI segmentation. (A) Correlation of LV mass derived from 
cardiac MRI (abscissa) versus post-mortem LV wet weight (ordinate). (B) Correlation of 
MI size, determined by TTC staining (abscissa) and LGE (ordinate). 
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4.2.12. Statistical Data Analysis 
Prism 5.0 (GraphPad Software, Inc., San Diego, CA) was used for most standard 
statistical analyses. All values are reported herein as mean ± standard deviation. Linear 
regression, and a correlation coefficient (R) value, was used to assess the agreement between 
two correlated parameters. The paired, two-tailed Student’s t-test was used for comparison 
between baseline and 2-day or 4-week MI groups. We also used the Bland-Altman analysis to 
assess the relative agreement of (1) MRI-derived LV mass and LV wet weight, and (2) LGE  
MR image and TTC staining measured infarction size. A p-value less than 0.05 was 
considered statistically significant for all comparison tests. 
4.3. Results 
4.3.1. Validation of MRI-Derived LV Mass and Infarct Size 
The measurements of LV wet weight were plotted against the corresponding 
calculated, MRI-derived LV mass data. A strong linear correlation was demonstrated (r=0.85, 
n=13, P<0.001); the slope was close to unity (0.85) with an intercept of 16.12, Figure 4.4A. 
A Bland-Altman analysis showed a mean difference of 0.03 mg between the two methods, 
with upper 95% limits of agreement at 14.29 mg, and lower 95% limits at -14.23 mg. MRI-
derived LV mass was 85.7 ± 8.7 mg at baseline, 93.9 ± 10.8 mg at 2 days and 97.6 ± 10.0 mg 
at 4 weeks post-MI. By comparison, the LV wet weight was 95.6 ± 10.4 mg at 4 weeks post-
MI, P =NS. Functional parameters measured from CINE MRI data are summarized in Table 
Table 4.1. Summary of functional parameters from MRI 
 
 LV EDV [μL] LV ESV [μL] LV EF [%] 
Baseline 50.6 ± 6.6 15.6 ± 3.7 69.7 ± 4.1 
2 Days 58.4 ± 13.9 29.6 ± 13.8 51.5 ± 14.1 
4 Weeks 98.3 ± 43.0 62.6 ± 41.7 41.9 ± 14.9 
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4.1, below. The mean of LGE MI size was 22.1 ± 9.1% (ranging from 7.5% to 35.4%) at 2 
days post-MI, and 15.8 ± 8.7% at 4 weeks post-MI. Post-mortem TTC measurements at 4 
weeks gave a mean of 15.3 ± 8.6%, Figure 4.5. 
4.3.2. Quantification of Regional Myocardial Dysfunction 
The percentage (%) of abnormal 3DK nodes (Z score ≤ -2.0) and RSAC nodes (Z 
score ≥ +2.0) observed in the chronic MI group at 4 weeks post-MI, averaged 55.4 ± 24.5% 
and 56.3 ± 23.6%, both markedly disparate and statistically different from TTC and LGE 
measurements of infarct size. As shown in Figure 4.5, the serial measurement of 3DK and 
RSAC demonstrated the dramatic change in the size of these territories between 2 days and 4 
weeks. Individual correlations between functional wall motion indices and LGE infarct size 
are shown graphically in Figure 4.6. At the 2-day time point, % abnormal 3DK, % abnormal 
RSAC, and LV EF correlated significantly (R = 0.74 0.82, and -0.81, respectively) with LGE- 
 
Figure 4.5. Time course of MI size. Comparison is between infarct size by histology 
(TTC, white circle) and MRI (LGE, white square) with percentage of abnormal functional 
indices (black markers). The differences in the measurement of MI size by LGE was not 
statistically different than any abnormal dysfunction indices at 2 days. However, at 4 
weeks, the % abnormal 3DK, RSAC, and %SA change were all significantly different from 
MI size measured by both LGE and TTC (p<0.001 for all 6 comparisons). 
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measured infarct size. Interestingly, the slope of the functional indices we introduce here was 
1.63 and 2.20 for 3DK and RSAC, respectively. This indicates that the disparity between 
 
Figure 4.6. Correlations of MI size with area of dysfunction. MI size was measured by 
LGE or TTC (ordinate) with % abnormal 3DK and RSAC, as well as ejection fraction (EF). 
Left column: LGE 2 days post-MI. Middle column: LGE 4 weeks post-MI. Right column: 
TTC 4 weeks post-MI. Of note are the upward shift between 2 days and 4 weeks, and the 
slopes of all lines, which indicate that the disparity between functional and structural 
measurements in these parameters increases with MI size. 
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LGE-measured infarct size and the size of the area of dysfunction increases with the size of 
the injury. 
It was notable that the linear correlations, segregated according to 2 days or 4 weeks 
post infarct, between LGE size and the Z scores for 3DK and RSAC were statistically very 
significant and strong, Figure 4.6, right two columns. However, while the slopes of these 
correlations were not statistically different between 2 days and 4 weeks, with the remodeling 
process each linear fit shifted upward, giving rise to different y intercepts between the two 
time points (see Discussion).  
4.3.3. Hemodynamics 
The results of hemodynamic measurements are shown in Figure 4.7 and summarized 
in Table 4.2. In addition to basal measurements, the responsiveness of all conventional 
micromanometer LV pressure parameters to beta-adrenergic receptor stimulation was defined 
and calculated as the slope of each relation to variable doses of dobutamine (0.75, 1.0, 2.0, 
4.0, 6.0, 8.0 μg/kg/min), Figure 4.7A-B. Notable was the inverse correlation between the LV 
dP/dt max to inotropic stimulation and the LGE infarct size at 4 weeks (r = -0.64, p<0.05), 
Figure 4.7C. Similar significant correlations were seen between this responsiveness slope of 
LV dP/dt max to dobutamine and the % abnormal 3DK and % abnormal RSAC, all of which 
support the prediction that LV force generation post-MI is inversely proportional to the size of 
an infarct and its associated regional dysfunction.  
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Figure 4.7. Correlation of MI size with inotropic contractile reserve. (A) LV pressure 
waveform (top), LV dP/dt max (bottom). (B) Contractile reserve is defined by the slope of 
LV dP/dt max to incremental increases of dobutamine concentration. Shown are means of 
all mice studied (n=11). (C) Contractile reserve was significantly correlated with LGE MI 
size for all mice with both hemodynamic and MR study data (n=10). 
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4.4. Discussion 
Using LGE magnetic resonance cross-sectional images, we have demonstrated the 
utility of 3D reconstruction of the mouse left ventricle for precise in vivo quantitation of both 
anatomic and functional indices of myocardial infarct size. We have shown that the 
gadolinium-labeled area of injury correlates highly with the magnitude of regional 
dysfunction, the global LV EF, and with both early and late post-injury contractile reserve. 
The 3D imaging technique also is valuable for its quantitation and display  
Table 4.2. Hemodynamic data 
 
Dobu. Dose [u] Parameter 
[units] 
Mean ± SD Parameter 
[units] 
Mean ± SD 
Basal (0) 
Heart rate 
[bpm] 
401.6 ± 29.4 
Max dP/dt 
[mmHg/s] 
5917.1 ± 974.5 
0.75 416.9 ± 33.3 6401.9 ± 949.9 
2 450.4 ± 31.5 8043.5 ± 2139.2 
4 477.6 ± 36.9 10380.0 ± 
2197.1 
6 512.1 ± 43.0 13327.5 ± 
3461.9 
8 545.9 ± 46.3 14982.5 ± 
2948.9 
Basal (0) 
Max pressure 
[mmHg] 
88.9 ± 7.7 
Min dP/dt 
[mmHg/s] 
-5127.2 ± 
1004.9 
0.75 93.0 ± 6.7 -5493.4 ± 847.9 
2 107.8 ± 21.9 -6295.6 ± 
1201.1 
4 120.7 ± 21.7 -7736.6 ± 
1239.0 
6 134.2 ± 23.7 -9457.4 ± 
2049.8 
8 135.2 ± 19.6 -10572.2 ± 
1853.4 
Basal (0) 
EDP [mmHg] 
5.0 ± 2.3 
Exponential Tau 
[ms] 
5.0 ± 2.3 
0.75 5.5 ± 2.5 5.5 ± 2.5 
2 6.7 ± 4.9 6.7 ± 4.9 
4 6.9 ± 4.7 6.9 ± 4.7 
6 7.8 ± 3.7 9.6 ± 1.5 
8 8.8 ± 3.7 8.7 ± 1.2 
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of the remodeling changes as the left ventricle dilates and the infarct area thins and expands, 
over a period of weeks post-infarct. We believe this approach has significant advantages over 
2D echocardiography for assessment in small animals of pharmacologic and genomic 
interventions aimed at mitigating infarct size and ischemic-reperfusion injury. Moreover, we 
observed a consistent and strong disparity between the size of the infarct and the area of 
dysfunctional tissue both at 2 days and 4 weeks post-MI. 
4.4.1. Territory of Regional Dysfunction in Mouse Model of Myocardial Infarction 
At 2-3 days after left anterior descending ligation, the parametric images (3DK or 
RSAC) demonstrated that the territory of myocardial dysfunction involved the anterior wall, 
extending over the anterolateral surface, and around the apex onto the apical-inferior segment 
of the LV. The distribution of the infarction territory is highly consistent with the distinctive 
features of mouse coronary artery anatomy as shown in C57Bl/6 mice published by Kumara, 
et al [28]. 
 
Figure 4.8.  Time course of MI zone nodes and correlation of 3DK and RSAC. (A) The 
evolution of the MI zone (defined as nodes with a Z score greater than 2.0 for RSAC or less 
than -2.0 for 3DK at 4 weeks). Mean Z scores for MI zone (#) and peri-MI zone ($) nodes 
of RSAC at 4 weeks were significantly greater than those at 2 days. Only mean Z scores for 
MI zone (*) nodes of 3DK were significantly different between the two time points. (B) 
RSAC and 3DK MI zone Z scores correlated significantly. 
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Most 2-day, 3DK parametric images showed a distinct area of hyperkinesis along the 
inferior-basal region of the LV, corresponding to the flow distribution of the mouse right 
coronary artery [28]. This territory of hyperkinesis appears to be dependent upon the size of 
the myocardial infarction, since hyperkinesis was less marked in those mice that sustained 
infarcts that covered a significantly smaller extent of the total surface area of the LV. This 
localized and compensatory hyperkinetic behavior at 2 days post-infarction, however, does 
not comport with Yang, et al, who concluded from a murine, 60 minute, ischemia-reperfusion 
model, using a 2D slice segmental analysis alone, that the fall in EF and rise in ESV at a 24-
hour time-point were due primarily to coincident reduction of percentage wall thickening in 
non-infarcted territory [10]. Their findings may be due to a 2D analysis of minor axis slices 
acquired at the mid-level of the LV, whereas our observation of hyperkinesis in 3D was in the 
high inferior-basal territory of the LV. Also, one cannot rule out differences in a given 
animal’s hemodynamic condition at the time when MR images were acquired. 
4.4.2. Chronic MI Model 
All of the animals in the chronic MI group underwent magnetic resonance imaging 
prior to the induction of the infarction, and, thus, served as their own controls. The protocol 
therefore allowed serial assessment of regional dysfunction, over 4 weeks of the relative 
change in LGE MI size and the evolution of regional and global LV dysfunction as the 
chamber remodeled in response to the regional injury. 
As shown in Figure 4.5B, LGE infarct size, at 4 weeks as opposed to 2 days, becomes 
significantly disparate from the magnitude of regional dysfunction, measured either by 3DK 
or RSAC. This might be expected as a result of the well-described progressive thinning, 
expansion, and fibrosis in the infarcted myocardium wall over a period of weeks following 
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loss of its blood supply [29]. Serial parametric images in a given mouse highlight the 
progressive dilation of the chamber and expansion of the territory of reduced myocardial 
shortening (Figure 4.3). It is also instructive to note that the linear correlation between LGE 
size and the percentage of regional dysfunction remained statistically significant both at 2 
days and at 4 weeks. The fitted line of the correlation shifted upward in most mice (except 
those with very small infarcts), giving rise at 4 weeks to a much larger territory of dysfunction 
for any given LGE infarct size (Figure 4.6, middle and right panels). Despite these dramatic 
regional changes with time, the correlation between LGE size and global EF remained nearly 
the same (Figure 4.6, bottom row). 
In order to track more specifically the behavior of the expanding infarct territory, we 
identified the nodes that were topographically situated within the area of regional dysfunction 
at 4 weeks (based upon a Z score beyond 2 standard deviations) and then retrospectively 
analyzed these same nodes on the 2 day scans. As shown in Figure 4.8A, these infarct nodes 
(MI zone) manifested progressively and significantly worsening Z scores between 2 days and 
4 weeks post-infarction. The degree of worsening myocardial shortening in the radial 
direction (3DK) appeared to be approximately the same in magnitude as the aggregate 
worsening in the circumferential and longitudinal direction (RSAC). Moreover, there was a 
highly significant inverse correlation between the average 3DK and RSAC Z scores for these 
MI zone nodes of each mouse, indicating that a displacement index incorporating shortening 
in the radial direction (3DK) provides no unique information as opposed to one reflecting loss 
of circumferential and longitudinal shortening (RSAC), Figure 4.8B. The parallel 
deformation of radial and endocardial surface components (circumferential and longitudinal) 
comports with a previous in vitro observation, which demonstrated isotropic behavior of 
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rodent myocardium in the region of a myocardial infarction at all time points between 1 and 6 
weeks after onset [30]. It is possible that these two indices could become more disparate if the 
expansion of the infarct worsened further beyond the time post-infarct when we carried out 
our final image. 
4.4.3. Inotropic Reserve and LGE MI Size 
As expected, at both 2 days and 4 weeks post infarction, 3DK and RSAC Z scores 
showed significant inverse correlations with conventional indices of LV global performance, 
including EF and basal LV dP/dt max. We queried further, however, whether contractile 
reserve, important to progressive levels of physical exertion, would correlate with our efforts 
to quantitate both anatomical and functional infarct size. We sought to identify a predictable 
relationship between myocardial infarct size and global LV contractile force generation in 
response to beta-adrenergic inotropic stimulation, both before and after the period of LV 
remodeling.  
Gerber et al. have previously described the relationship of regional myocardial strain 
function and LGE myocardium, and concluded that inotropic reserve was confined to remote 
myocardium, or areas with non-transmural infarction. Transmural infarction demonstrated 
absence of inotropic response, and was believed to indicate irreversibly injured myocardium 
[14]. 
At 4 weeks, when comparing LGE MI size and the slope of the incremental response 
of isovolumic max dP/dt to graded doses of dobutamine, we found a highly significant 
correlation (R = -0.64), Figure 4.7C. This observation indicates that LGE infarction size is an 
inverse determinant of the global inotropic contractile reserve at 4 weeks post-MI. It also 
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implies that testing of this slope provides a useful approach for the assessment of 
pharmacologic and cellular interventions aimed at restoring global LV function post-MI. 
4.4.4. Limitations 
Different anesthetic agents were used for the acquisition of MRI scans (1.5-2.0% 
isoflurane) and hemodynamic variables (xylazine and ketamine). These agents may cause 
some differing effects on mouse cardiac function, and thus the correlation of MR-derived LV 
function parameters and hemodynamic indices should be interpreted with that caveat. The 
agreement of LV mass by MRI and wet LV weight was not as close as previous studies [3], 
[22], although it may be due to our smaller sample size, limited extent of axial MR image 
data, and an increased variability of our LV volume determinations. 
4.5. Conclusions 
This experimental in vivo murine 3D imaging study has shown that LGE-MR 
determined infarction size, measured either early or late following a myocardial infarction, is 
linearly correlated with the percentage of regional dysfunction as well as the EF. Moreover, 
global LV inotropic reserve, as measured by responsiveness to dobutamine, is highly 
correlated with the magnitude of LGE labeling.  
The 3D reconstructed model of multiplanar slices has now been shown to be a 
powerful tool for quantitating, localizing and visualizing regional myocardial dysfunction in 
the mouse left ventricle. The percentage abnormal 3DK and percentage abnormal 3D RSAC 
both serve as myocardial shortening indices that can be followed serially while the left 
ventricle remodels and dilates in response to myocardial infarction. Despite wall thinning in 
the post-MI heart, the calculation of these regional shortening indices, based on endocardial 
border tracing, remains automatically definable.  
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The success of 3D reconstructed MR images in this small animal model of myocardial 
infarction portends a valuable application of the same technique in man for improved 
prognostication and assessment of therapeutic interventions.  
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5. Conclusion to the Dissertation 
In this work, I have shown that regional variations in structural features are very 
common in the mammalian ventricles, and that such regional variation helps to optimize 
ventricular function in the normal ventricle. Furthermore, disruptions to the distribution of 
such structures, e.g. during disease, lead to complex, spatially heterogeneous dysfunction. 
Specifically, in Chapter 2 I showed that pressure overload alters the regional 
distribution of key electrophysiological and calcium handling proteins such as SERCA2a and 
Cx43, which are known to affect regional tissue mechanics and therefore overall ventricle 
pump function. These distributions were previously unclear in the rat ventricles and provide 
useful experimental data for generating computational models of ventricular mechanics to 
better understand the contributions of protein structures to pump function. 
The spatial organization of left ventricular microstructure is known to have a marked 
effect on functional efficiency. In Chapter 3, we found that the transmural gradients in 
myocyte geometry and sheet dispersion are diminished in pressure overload. We also 
demonstrated that these structural features can be detected consistently via DT-MRI, which is 
non-invasive, non-destructive, comprehensive, and efficient compared to histological 
methods.  
Lastly, in Chapter 4 we showed that a 3D, comprehensive approach to measuring the 
extent of injury during myocardial infarction using MRI-derived computational models of 
ventricular geometry are superior to traditional methods of measuring infarct size and 
dysfunction. We specifically showed that the area of regional dysfunction is significantly 
larger than the size of a measured infarction, and that this disparity increases with the duration 
of the coronary occlusion. This novel method for quantifying 3D dysfunction in the mouse is 
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useful because it provides a straightforward way to more accurately quantify the effect of a 
pharmacologic or cell-based treatment on regional function and will enable researchers to 
better identify whether a treatment has any beneficial effect. 
Future work could enhance and clarify the findings presented herein. The regional 
distribution of the proteins examined in Chapter 2 could be more comprehensively 
characterized with a more consistent histological approach, as long as objective quantification 
was successfully implemented. Additionally, only a handful of select electrophysiological and 
calcium handling proteins were investigated, even though there are myriad proteins with 
important functions that vary regionally and are altered during disease. Building a library of 
3D heterogeneous protein densities in normal and diseased hearts would be beneficial for 
building computational models of ventricular mechanics. Such models provide an excellent 
means to identify key contributors to dysfunction during disease. 
Although the correlations between regional variations in tissue microstructure and 
DTI-derived parameters (Chapter 3) were statistically significant, it is possible that other 
structural features are involved in modulating the DT-MRI signal. A critical study that has not 
been done would be to model a diffusion MRI experiment in computational models of cardiac 
tissue microstructure in order to determine the relative contributions of altered structural 
properties to parameters such as anisotropy. Such computational methods would also allow 
for separating the otherwise linked variations in fiber or sheet dispersion and linear or planar 
anisotropy, respectively. The diminished gradient of myocyte geometry in pressure overload 
undoubtedly affects ventricular mechanics, but because of the complexity of ventricular 
structure and function, understanding how they do so is not straightforward. Again, 
computational models of left ventricular mechanics constitute an ideal method for 
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determining this effect, especially if combined with protein density distributions or other 
known forms of remodeling. 
The 3D regional dysfunction we observed in Chapter 4 was wholly dependent on 5-7 
1-mm thick short-axis slices that spanned the length of the left ventricle. Because of 
longitudinal (through plane) deformation and the limits of MR imaging, including the partial 
volume effect, there is undoubtedly error in the calculation of endocardial geometry. One 
simple way to improve this method is to acquire two to three long-axis slices, which would 
help to define the curvature and function of the apex, as well as define more concretely the 
valve plane so that the model spans the entire ventricle. Indeed, we have already begun 
implementing this improvement and seen a beneficial effect [unpublished data].  
A major bottleneck to this approach is manual segmentation of ENDO and EPI 
borders. Convolutional neural networks may provide a much faster, automated approach to 
segmentation that would remove the current bottleneck and make this method even more 
useful to the research community. We have begun developing such a tool using available data 
from human cardiac cine-MRI scans with promising results. However, it must be cautioned 
that the quality of segmentation has a very strong influence on the results of this type of 
analysis and so any automated method to perform the segmentation must be extremely well 
tuned, or the benefit would be lost. Semi-automation would remain as a potential approach. 
As shown in this dissertation, generalizations from global or localized measurement 
are insufficient to characterize structure-function relationships in the heart, whereas regional 
variations in structure and function are critical to understanding normal pump function and the 
spatially heterogeneous remodeling response that occurs in cardiac disease. 
